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What is a scientist after all?  
It  is a curious man looking through a keyhole, the keyhole of nature, 
trying to understand what’s going on. 
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1 Summary 
Macromolecular exchange between the nucleus and the cytoplasm is mainly mediated by 
the RanGTP-dependent nuclear transport receptors (NTRs) of the Impβ family. NTRs are 
classified as importins and exportins according to the direction of transport. Exportins 
carry their cargos from the nucleus to cytoplasm as a ternary export complex together with 
RanGTP. Impβ-like NTRs are made up of multiple HEAT repeats and share an inherently 
flexible structure. Nevertheless, structural analyses so far revealed unique cargo 
recognition mechanisms for each NTR, and even for different cargos recognized by the 
same receptor. 
Actin is the well-known constituent of the cytoplasmic microfilaments. Monomeric actin 
with its small size and globular fold can slowly diffuse into the nucleus. Exportin 6 (Xpo6) 
is a dedicated export receptor found in vertebrates and insects, whose only known function 
is to export nuclear actinprofilin back to cytoplasm. In the absence of Xpo6, actin 
accumulates in the nucleus. Amphibian oocytes exploit this to stabilize their giant nuclei 
with an intranuclear actin cytoskeleton by blocking Xpo6 expression. On the other hand, 
nuclear accumulation of actin is also seen in intranuclear rod myopathies (IRM), 
devastating muscle diseases caused by several mutations of the skeletal alpha actin gene. 
We hypothesize that these mutations of actin interfere with its recognition and nuclear 
export by Xpo6, resulting in the characteristic nuclear accumulations. 
To decipher the cargo recognition by Xpo6 and to understand the mechanisms underlying 
the IRM, we set out to crystallize the Xpo6RanGTPactinprofilin complex. It turned out 
that the actin export complex is extremely salt sensitive, and muscle and non-muscle actin 
isoforms differ in their affinity for profilin and hence, for the export complex. We 
developed a new single-step protocol for purification of profilinβ/γ-actin complexes from 
cytoplasmic extracts, which enabled us to purify a stable actin export complex. 
Topological analysis of the actin export complex showed that the Poly-Proline-binding 
pocket of profilin is accessible in the complex, whereas the binding site for DNaseI on 
actin overlaps with the Xpo6 binding site. Crystals of cargo-free Xpo6 were obtained in 
several different conditions. However, the diffraction is currently limited to 7.4 Å 
resolution. Also the actin nuclear export complex was successfully crystallized. These 
crystals will be the substrates for future structural analyses and will help us to understand 
the cargo recognition by Xpo6. 
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2 Introduction 
2.1 The nucleus 
One of the key “inventions” in evolution is the organization of eukaryotic cells into 
membrane bound compartments. Confining certain processes to specific compartments 
allows the cell to carry out counteracting reactions simultaneously, and complementary 
reactions sequentially. More importantly, compartmentalization equips the cell with a 
tighter control over these processes. Advantages of compartmentalization can be best 
understood by the fact that only eukaryotes developed into complex multicellular 
organisms. 
Nucleus is the defining compartment of a eukaryotic cell. It encloses the genome; separates 
DNA replication, DNA repair, transcription and mRNA processing (splicing of introns, 
polyadenylation, capping) events from the cytoplasmic translation, spatially and 
temporally. Nuclear mRNAs are only exported into the cytoplasm after being processed, 
which ensures that only the processed mRNAs are translated. This allows a level of control 
that makes intron-bearing genes possible. Intron-containing genes and alternative splicing 
provide increasing complexity to eukaryotes on functional level, without increasing the 
genome size proportionally. Also, containment of the genome in a specialized organelle 
protects it from mechanical and metabolic damage, and pathogens, increasing the genomic 
stability and enabling eukaryotes to handle larger genomes.  
2.1.1 The nuclear pore complex  
Nuclear envelope (NE) is a double membrane structure that defines the borders of the 
nucleus. The inner membrane of the NE faces the nuclear interior, whereas the outer 
membrane is continuous with the endoplasmic reticulum (ER) and faces cytoplasm. The 
space between the inner and the outer nuclear membranes (perinuclear space, PNS) is as 
well continuous with the ER lumen (Watson, 1955; Subramanian and Meyer, 1997). The 
nuclear envelope is punctured with disc-shaped openings, the nuclear pores, where the 
otherwise parallel outer and inner membranes of the NE meet (Watson, 1954). Nuclear 
pores are decorated with gigantic proteinaceous assemblies with octagonal symmetry, 
called nuclear pore complexes (NPCs) (Watson, 1959). NPCs are the main routes for 
nucleocytoplasmic exchange in the cell (Feldherr, 1962). 
   9 
 
Figure 2-1 Nucleus, nuclear envelope and the nuclear pore complex 
(A) Electron micrograph of pancreatic acinar cell nucleus from the bat Myotis lucifugus. (Fawcett, 1981). (B) Schematic 
representation of the nuclear membrane and NPCs (Alberts et al., 2007). Nuclear pore complexes have octagonal 
symmetry, which is easily recognized by observing the cytoplasmic fibrils and the nuclear basket (C) Cytoplasmic face of 
Xenopus laevis nuclear envelope and the nuclear pore complexes. Scale bar 200nm (Allen et al., 2007). (D) Nuclear 
basket of a single NPC from Xenopus laevis nuclear envelope. Scale bar 50 nm (Allen et al., 2007). (E) Side view of the 
nuclear envelope perforated with NPCs (Alberts et al., 2007). 
 
The NPC is one of the largest complexes found in the cell with molecular weight reaching 
≈66 MDa for yeast NPCs (Rout and Blobel, 1993; Yang et al., 1998) and ≈125 MDa for 
vertebrate NPCs (Reichelt et al., 1990). Despite its large size, the NPC is made up of only 
30 different proteins, nucleoporins (Nup), which are present in multiple copies in the 
complex (see (Ori et al., 2013) for exact stoichiometries). Nups can be classified according 
to their location within the NPCs. Transmembrane Nups anchor to the NE and provide 
base for the channel to be build on. Scaffold Nups form the ring-like structure that 
surrounds the periphery of the central channel. Another class of Nups have dispersed 
phenylalanine-glycine (FG) repeats and these FG domains lack a defined fold (Denning et 
al., 2002, 2003). The FG-Nups bind to the scaffold and plug the center of the channel via 
their FG domains, fulfilling a barrier function. The structural organization of the NPC 
proteins within the pore and the principles of the NPC permeability barrier are not yet fully 
resolved. One of the best models to explain the NPC permeability barrier is the “selective 
phase” model (Ribbeck and Gorlich, 2001). The model states that the FG-Nups form a 
meshwork through inter- and intramolecular interactions via the FG repeats, which forms 
an aqueous passive diffusion barrier. This meshwork excludes inert molecules larger than 
the passive diffusion limit (5 nm), whereas molecules smaller than this limit can diffuse 
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through this sieve-like structure. Molecules larger than the passive diffusion limit require 
assistance of specialized soluble receptors for nuclear transport, which can dissolve their 
way through this meshwork by interacting with the FG repeats. 
2.2 Nucleocytoplasmic transport 
The separation of the cytoplasm and the nucleus comes at the cost of active and selective 
transport between the two compartments. Translation being a solely cytoplasmic process, 
all the nuclear proteins that are needed for DNA stability, replication and repair, proteins 
necessary for transcription, RNA processing and gene expression regulation have to be 
imported from the cytoplasm. On the other hand, translation strictly depends on nuclear 
products such as the mRNAs, tRNAs, and the ribosomal subunits, which have to be 
exported from the nucleus.  
Nucleocytoplasmic transport is an essential activity for the cell. In order to keep the 
cytoplasmic and nuclear contents separated and to move the necessary macromolecules 
across the NPC, the cell invests considerable amounts of energy and dedicated proteins. 
The following calculations give an impression about the extent of the energetic investment: 
a proliferating HeLa cell uses a nuclear transport capacity of ~20 MDa per NPC per 
second, which approximates to a total mass flow of >200 GDa per second between nucleus 
and cytoplasm (Ribbeck and Gorlich, 2001). Both passive diffusion and facilitated 
transport contribute to the material exchange through the NPC. 
2.2.1 Passive diffusion 
Small molecules and proteins up to 5 nm in diameter (20-40kDa) can freely diffuse 
through the NPC permeability barrier, whereas larger proteins require assistance for 
efficient translocation (Mohr et al., 2009). Passive diffusion does not require specific 
interactions between the translocating species and the NPC. Small proteins that are equally 
distributed between cytoplasm and nucleus and almost all metabolites and ions passively 
diffuse through the NPC. 
2.2.2 Facilitated translocation 
Most of the molecules that cross the NPC in either direction are indeed too large to be let 
through by the permeability barrier. Such molecules traverse the NPC with the aid of 
specialized soluble receptors. The nuclear transport receptors (NTRs) of the Imp β family 
have the ability to dissolve into the FG meshwork of the NPC, explaining the rapid 
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translocation rates of the NTRs compared to passive diffusion events (Ribbeck and 
Gorlich, 2001).  
A facilitated active transport, however, is not only required for the large molecules. 
Proteins with regulatory function, including the transcription factors, are needed in the 
nucleus only at certain times. Obviously, passive diffusion for such molecules can not 
provide the necessary strictness. Like only the processed mRNAs being exported from the 
nucleus, these molecules can interact with their corresponding NTRs only when they 
represent the required properties. Regulating the NPC passage of such molecules by NTRs 
is an elegant solution to the problem.  
NPC forms a tight, yet imperfect barrier. Even proteins that are slightly larger than the 
diffusion limit may slowly cross the NPC. This becomes more prominent, when long time 
scales are considered for the passive influx. For this reason, the lack of an active import 
mechanism does not guarantee the exclusion of a protein from nucleus. Specific nuclear 
exclusion requires an active export mechanism, which can work against a free 
concentration gradient, unlike the passive diffusion. 
For example, the major cytoskeletal protein actin is 42 kDa in its monomeric form and can 
slowly diffuse into the nucleus (De Robertis et al., 1978). Since actin can reach 
cytoplasmic concentrations of about 200 µM (Alberts et al., 2002), it is essential that the 
leakage is counteracted by active transport. Exportin 6 is a specialized NTR, whose only 
function is to pump actin back into the cytoplasm (Stuven et al., 2003). The importance of 
the active transport becomes evident, when the polymerization capability of actin is 
considered. In the absence of the actin binding proteins to keep it monomeric, actin can 
quickly polymerize in the nucleus and interfere with the nuclear processes. 
2.2.3 Ran and the RanGTP gradient 
A 25 kDa GTP binding protein, Ran (Ras-related nuclear antigen) (Bischoff and Ponstingl, 
1991a), provides directionality to the active nucleocytoplasmic transport (Gorlich et al., 
1996b). Ran can be found in two distinct nucleotide bound states, RanGTP and RanGDP 
(Gorlich et al., 1996b). Upon the hydrolysis of the gamma phosphate, the core of the 
protein (G-domain) remains mostly unchanged, whereas three regions, called switches, 
assume drastically different conformations. For details of the conformational changes of 
Ran, see Figure 2-2. These conformational changes make the GTP and GDP states of Ran 
functionally distinct. RanGTP (active form) binds to NTRs with high affinity, where 
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RanGDP (inactive form) does not. The directionality of the active nuclear transport is 
determined by the differential localization of Ran species on either side of the NE. In the 
nucleus, RanGTP concentration is approximately 1000 fold higher than the cytoplasm 
(Gorlich et al., 2003). This steep concentration gradient is the driving force of facilitated 
translocation (Gorlich et al., 1996b).  
 
Figure 2-2 Conformational changes in Ran upon nucleotide exchange 
Ran is shown in GDP and GTP bound states. For emphasis on the conformational changes, three main switch regions are 
colored in green (switch I, residues 30-47), in orange (switch II, residues 65-80) and in blue (C-terminal switch, residues 
177-216). In the GDP bound state, Ran represents a more compact folding, with the C-terminal switch folded back onto 
the protein core. At the extreme C-terminus of Ran an acidic DEDDDL motif, which is not resolved in the crystal 
structure, is most likely to fold on a basic patch on the protein core. The switches I and II do not contact the nucleotide.  
Upon nucleotide exchange, major rearrangements occur in the molecule. Switch I undergoes a drastic conformational 
change, now making extensive contacts with the nucleotide. The changes in switch II are more subtle but no less 
important. Switch II bears the Gln 69 residue, which is essential for GTP hydrolysis, and with this subtle change in 
switch II, it is brought to close proximity to the γ phosphate of GTP. C-terminal switch is now in an extended 
conformation and does not contact the core. The basic patch, which becomes free in the GTP conformation, is important 
for contact with NTRs. The conformation of the C-terminal switch will depend on the binding partner, which in this case 
is RanBP1. Ran GTP is taken from the structure with PDB-ID: 1K5D (Seewald et al., 2002). RanGDP is taken from 
crystal structure with PDB-ID: 3GJ0 (Partridge and Schwartz, 2009). The representation was prepared using PyMol. 
 
Several proteins are involved in creating and maintaining this gradient. The intrinsic 
GTPase activity of Ran is very low, such that the GTP hydrolysis strictly depends on the 
Ran GTPase activating protein RanGAP (Bischoff et al., 1994; Klebe et al., 1995). 
RanGAP, however, can not act on a RanGTP molecule that is bound to an NTR. For the 
removal of Ran from the NTR, additional proteins are required. RanBP1 or RanBP2 
(Nup358) help to destabilize the NTR⋅RanGTP complexes and the eventual hydrolysis of 
GTP together with RanGAP (Bischoff and Gorlich, 1997). RanBP2 is a part of the NPC on 
the cytoplasmic side (Yokoyama et al., 1995), whereas RanBP1 and RanGAP are kept 
exclusively cytoplasmic (Matunis et al., 1996; Richards et al., 1996; Mahajan et al., 1997). 
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It is important that all these proteins are confined to the cytoplasm, to ensure that the GTP 
hydrolysis only takes place in this compartment. A fraction of soluble RanGAP is 
SUMOylated and is recruited to the cytoplasmic side of NPC via RanBP2 (Matunis et al., 
1996). This localization of RanGAP not only serves a rapid recycling of the NTRs, but also 
ensures that the steep RanGTP gradient is maintained across the NE.  
On the nuclear side of the NE, another protein acts in the opposite way: generation of 
RanGTP. The chromatin bound guanine nucleotide exchange factor of Ran, RCC1 
(regulator of chromosome condensation 1) catalyzes the exchange of Ran bound GDP to 
GTP, and constantly replenishes the nuclear RanGTP levels (Bischoff and Ponstingl, 
1991b). It is essential to confine the regulatory proteins to their respective compartments, 
in order to create and maintain the RanGTP gradient across the NE (Izaurralde et al., 
1997). 
2.2.4 Nuclear import and export cycles 
NTRs shuttle between the cytoplasm and the nucleus, bind to their cargos via specific 
signals, carry them through the NPC, and release them on the destination site (Gorlich and 
Kutay, 1999). NTRs are classified according to their transport directions: importins 
(Gorlich et al., 1994) bind their cargos in the cytoplasm and release them in the nucleus; 
and exportins (Fornerod et al., 1997) bind their cargos in the nucleus and release them in 
the cytoplasm. A more detailed analysis of the NTRs of Imp β superfamily will be 
presented in the section 2.3. Importins bind their cargos in the cytoplasm, where RanGTP 
concentration is low. Upon translocation to the nucleus, RanGTP dissociates the 
importincargo complex. Cargo is released and the RanGTP bound importin shuttles back 
to the cytoplasm. In the cytoplasm, RanGTP is dissociated from the importin making it 
available for another round of transport. Exportins, on the other hand, bind their cargos in 
the nucleus together with RanGTP. There is cooperativity in cargo and RanGTP binding, 
such that binding of RanGTP increases the affinity towards the cargo and vice versa. The 
ternary export complex translocates through the NPC, and is dissociated upon reaching the 
cytoplasm. Cargo and Ran are released, and the free exportin shuttles back to nucleus for 
another round. 
As described, both import and export cycles result in the removal of one RanGTP from the 
nucleus per cycle. A small transporter, Nuclear Transport Factor 2 (NTF2), shuttles Ran 
back to the nucleus counteracts this constant RanGTP drain. NTF2 is a 15 kDa protein that 
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works as a homodimer and imports two RanGDP molecules to the nucleus (Moore and 
Blobel, 1994; Ribbeck et al., 1998). In the nucleus RanGDP is converted to RanGTP by 
RCC1 and is released from the NTF2. Figure 2-3 gives an overview of nuclear import and 




Figure 2-3 Overview of nucleocytoplasmic transport  
The scheme summarizes the nuclear import, export and Ran cycles. Importins are abbreviated as Imp, exportins as Exp. 
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2.3 Nuclear Transport Receptors 
To date, there are more than 20 NTRs of the Importin β superfamily known in mammals. 
While most NTRs are dedicated to either import or export, there are also NTRs shown to 
work in both directions with different cargos. Table 2-1 shows a list of functionally 
characterized mammalian NTRs and a selection of their respective cargos. 
Table 2-1 Mammalian nuclear transport receptors and selected cargos 
NTR Selected cargos References 
Export receptors 
Exportin 1 (CRM1) Leu-rich NES cargos 
HIV-Rev 
Snurportin1 
60S ribosomal subunit•Nmd3 
(Wen et al., 1995) 
(Fischer et al., 1995) 
(Fornerod et al., 1997)  
(Fukuda et al., 1997) 
(Paraskeva et al., 1999)  
(Trotta et al., 2003) 
Exportin 2 (CAS) Importin α (Kutay et al., 1997) 
Exportin 3 (Exp-t) tRNA (Kutay et al., 1998) 
Exportin 5 (Xpo5) aa-tRNA•eIF1A  
dsRNA binding proteins  
pre-miRNA 
(Bohnsack et al., 2002) 
(Brownawell and Macara, 2002) 
(Bohnsack et al., 2004) 
Exportin 6 (Xpo6) actin•profilin (Stuven et al., 2003) 
Exportin 7 (Xpo7) p50RhoGAP, 14-3-3σ (Mingot et al., 2004) 
Import receptors 
Importin β (Impβ) Ribosomal proteins 
HIV Rev, HIV Tat proteins 
Snurportin•m3Gcap-UsnRNPs 
XRIPα•RPA 
(Jakel and Gorlich, 1998) 
(Truant and Cullen, 1999) 
(Huber et al., 1998) 
(Jullien et al., 1999) 
Importin β / importin α Classical NLS cargos (Gorlich et al., 1994) 
(Gorlich et al., 1995) 
Importin β / importin 7 Histone H1 
 
(Jakel et al., 1999) 




(Pollard et al., 1996) 
(Jakel and Gorlich, 1998)  
(Muhlhausser et al., 2001) 
(Dean et al., 2001) 
Transportin-SR SR proteins 
 
(Kataoka et al., 1999) 
Importin 4 (Imp4) Ribosomal proteins (Jakel et al., 2002) 
Importin 5 (Imp5) Ribosomal proteins 
histones 
(Jakel and Gorlich, 1998)  
(Muhlhausser et al., 2001) 
Importin 7 (Imp7) Ribosomal proteins 
histones 
(Jakel and Gorlich, 1998)  
(Muhlhausser et al., 2001) 
Importin 8 (Imp8) SRP19 
Argonaute proteins 
(Dean et al., 2001)  
(Weinmann et al., 2009) 
Importin 9 (Imp9) Histones 
Ribosomal proteins  
(Muhlhausser et al., 2001)  
(Jakel et al., 2002) 
Importin 11 (Imp11) UbcM9 
Ribosomal protein L12 
(Plafker and Macara, 2000)  
(Plafker and Macara, 2002) 
Bidirectional receptors 
Importin 13 (Imp13) Mago-Y14, hUBC9 (import) 
eIF1A (export) 
(Mingot et al., 2001) 
Exportin 4 (Xpo4) eIF5A, SMAD3 (export) 
Sox2, SRY (import) 
(Lipowsky et al., 2000) (Kurisaki 
et al., 2006) 
(Gontan et al., 2009) 
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2.3.1 Structural features of Impβ family NTRs  
All members of the Impβ family of NTRs are sequence related to importin β. Additionally, 
they all share common features like their large sizes (90-140 kDa), relatively acidic 
isoelectric points (4.0-6.0), their ability to bind Ran (Gorlich et al., 1997), their ability to 
interact with FG nups (Iovine et al., 1995; Bayliss et al., 2000; Bednenko et al., 2003) and 
with phenyl sepharose matrix (Ribbeck and Gorlich, 2002). NTRs also share a common 
overall architecture. The smallest structural unit is the HEAT repeat, named after the first 
class of proteins identified to contain them: huntingtin, elongation factor 3, the PR65/A 
subunit of protein phosphatase 2A (PP2A) and the lipid kinase TOR (Andrade and Bork, 
1995). A HEAT repeat is composed of two antiparallel alpha helices connected by a short 
intrarepeat linker. NTRs are usually made up of ~20 tandem HEAT repeats, all arranged in 
a slightly shifted angle to give rise to a right-handed superhelix (Figure 2-4). If the helices 
of a HEAT repeat are denoted as A and B; in an NTR, A helices face outward and B 
helices face inward. The helices contain hydrophobic residues that form the intra- and 
inter-repeat interfaces, which also might represent the hydrophobic pockets that are 
necessary for the interaction with FG nups. Despite their similarities, NTRs share 
surprisingly low overall sequence homology (sequence identity is around 8-15%). The 
highest sequence homology is observed in the N-terminus, which the most acidic region 
and accounts for the Ran binding activity (Gorlich et al., 1997). 
 
Figure 2-4 HEAT repeat architecture of Importin beta 
Importin beta from the structure 2BKU (importin beta – RanGTP) (Lee et al., 2003) is depicted in two different 

























importin ћ HEAT repeats
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starting from the N-terminus. The A helices of each repeat (shown in orange) faces the outside of the solenoid, whereas 
the B helices (shown in green) line up the inner surface. The intra- and inter-repeat loops are colored in gray. Impβ has 
19 HEAT repeats, but this number can vary in other NTRs (CRM1 has 21 HEAT repeats). 
 
2.3.2 Nuclear transport signals 
As mentioned earlier, the facilitated transport is a tightly controlled process. Where some 
NTRs carry only one specific cargo, like CAS (importin α) (Kutay et al., 1997) and 
Exportin 6 (actin) (Stuven et al., 2003); some other NTRs recognize a large variety of 
cargos, such as CRM1 (Monecke et al., 2009) and Importin α/β (Gorlich et al., 1995). 
NTRs that transport many different proteins utilize certain signals to recognize their cargo, 
termed as nuclear import and nuclear export signals. 
The first nuclear localization signal (NLS) to be identified was from the Large T-antigen of 
Simian Virus 40 (Kalderon et al., 1984a, 1984b). This sequence was a short patch 
containing basic amino acids: PKKKRKVE. Another type of basic NLS was later 
identified in Xenopus laevis nucleoplasmin (Robbins et al., 1991). In this case, the NLS 
consisted of two basic patches separated by a short spacer. The “monopartite” SV40 type 
and the “bipartite” nucleoplasmin type signals are collectively referred as the classical 
NLSs (cNLS). These sequences, when fused to cytoplasmic proteins, were enough to result 
in a nuclear localization. Later, many other nuclear proteins have been identified with 
similar basic patches. The mechanism of the Imp α/β mediated import was understood 
much later than the identification of the signals that drive proteins into the nucleus. The 
cNLSs are recognized by importin α, which in turn interacts with importin β through its 
importin β binding (IBB) domain (Gorlich et al., 1995, 1996a). Considering that most 
DNA binding motifs consist of exposed basic patches, it is an elegant mechanism to use 
basic patches for nuclear import in order to sort such DNA-interacting proteins to nucleus 
via their functional domains. Another function that importins (Imp4, Imp5, Imp7, Imp9, 
Impβ) fulfill by recognizing exposed basic patches in ribosomal proteins and histones is to 
prevent them from ionic aggregation in the cytoplasm (Jakel et al., 2002). In that way, 
importins function as chaperones for basic patches, like heat shock proteins for 
hydrophobic regions. 
CRM1 is the main export receptor in the cell, responsible for the nuclear exclusion of 
many proteins and complexes that vary in size and function. CRM1 cargos, as versatile as 
they are, share a common Leu-rich signal that confer binding to CRM1, the classical 
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nuclear export signal (NES). The first NES was discovered in the Protein Kinase A 
Inhibitor (PKI): a short stretch of interspersed hydrophobic amino acids was found to be 
responsible for nuclear exclusion (Wen et al., 1994). Another type NES was identified in 
the HIV protein Rev, which had a different spacing of the hydrophobic residues (Fischer et 
al., 1995; Wen et al., 1995). Later on, other proteins with similar hydrophobic stretches 
have been shown to bind CRM1. CRM1 has a hydrophobic cleft created by the HEAT 
repeats 11 and 12 and the NES nicely fits into this hydrophobic groove (Monecke et al., 
2009). A more comprehensive study later revealed the structural basis for the NES-CRM1 
interaction (Guttler et al., 2010). This study revised the known consensus sequences so far 
by showing that there is another hydrophobic residue at the N terminus of the known 
stretch involved in the binding. It also showed that the unstructured PKI and Rev type 
NESs assume different conformations to fit their hydrophobic residues to the hydrophobic 
pockets of the CRM1 cleft. 
The classical nuclear transport signals do not explain all nuclear transport events. The 
NTRs with a limited number of cargos usually make extensive surface contacts with their 
cargo. Hence, one can talk about a three dimensional recognition of the substrate. These 
interactions have to be unraveled individually to understand the dynamics of the cargo and 
the respective NTR.  
2.3.3 Cargo recognition by NTRs 
The helical construction of NTRs makes them inherently flexible, which is core to their 
cargo recognition (Conti et al., 2006; Cansizoglu and Chook, 2007). Exportins 
accommodate RanGTP and their cargo at the same time, where the binding of one 
increases the NTR affinity towards the other. The cooperativity in cargo and Ran binding 
is caused by direct interactions of Ran and the cargo, and by the conformational changes 
throughout the molecule. CRM1 presents a special example where RanGTP and the cargo 
do not contact each other in the ternary complex (Monecke et al., 2009). Ran binds to the 
inner surface of the NTR, whereas cargo is accommodated on a cleft on the outer surface. 
Despite the positional distance of the cargo and RanGTP, CRM1 can only bind cargo when 
Ran is bound to it. The conformational changes upon Ran binding are propagated via 
flexible HEAT repeats, such that the hydrophobic cleft at the other end of the molecule 
assumes an open conformation for cargo binding.  
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For other NTRs with specific cargos such as CAS or Exportin-t, cargo (imp α and tRNA 
respectively) is accommodated on the inner surface of the molecule, where it also has 
direct contacts with Ran (Matsuura and Stewart, 2004; Cook et al., 2009). This direct 
interaction contributes greatly to the cooperativity of cargo and Ran binding to the NTR 
(Kutay et al., 1997, 1998). In addition to the direct contact of Ran, the NTRs themselves 
undergo drastic conformational changes to accommodate the cargo (Guttler and Gorlich, 
2011). Exportin 6 is also a very specific NTR, whose only known cargo is actinprofilin 
complex. Whether Exportin 6 engulfs its cargo like CAS and Exportin-t, or whether actin 
contacts Ran in the export complex remains to be elucidated. 
In most cases, the way an NTR interacts with its cargo can not be pre-determined without 
structural evidence. The flexible construction of NTRs enables them to assume very 
different conformations to specifically interact with a given cargo. Importin β, for example, 
has been crystallized with many different cargos so far, and found to assume a different 
conformation each time (Vetter et al., 1999; Lee et al., 2003; Mitrousis et al., 2008; Choi 
et al., 2014). This holds true for other NTRs as well. The crystallographic data shows that 
cargo recognition by NTRs can be quite different than another (Figure 2-5). This makes it 
impossible for us to predict any mechanisms for NTR-cargo interaction without structural 
evidence. To date, several NTRs have been structurally characterized, however, there are 
still many of them that are waiting to be investigated. How exportin 6 recognizes actin will 
be the main question we will try to address in this study.  
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Figure 2-5 Comparison of structurally characterized exportins in cytoplasmic and nuclear states 
This figure (Guttler and Gorlich, 2011) shows a structural comparison of the exportins that are structurally characterized. 
The receptors are shown in blue surface representation, Ran is shown in green and the cargo is shown in orange. The 
structure of the cargo-free CRM1 (Monecke et al., 2013) is added to the figure for complementation. The direction of 
movement upon cargo binding is indicated with red arrows on the left panel. Despite their similar constructions, 
exportins here are shown to assume drastically different conformations during the recognition of the cargo. In its free 
form CAS has a closed conformation, whereas Exportin-t is widely open. CAS opens up to accommodate Ran and Impα, 
whereas Exportin-t assumes a more packed conformation when it is bound to Ran and tRNA. Also note that the extent of 
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2.4 Actin 
Actin is one of the major constituents of the cytoskeleton and also one of the most 
abundant proteins found in all eukaryotic cells. The main function of actin is to polymerize 
into microfilaments that form the cytoskeleton, and it is essential for cellular functions like 
cell division, vesicle trafficking, migration and cell shape regulation. Actin is involved in 
more protein-protein interactions than any other known protein, and has very complex 
dynamics as the main cytoskeletal component. It would therefore be a tremendous task to 
introduce actin from every aspect. For this reason, I will mainly focus on the isoforms, 
structure, binding partners and the nucleocytoplasmic distribution of actin in the following 
sections and refer to reviews for further details. 
2.4.1 Isoforms of actin 
Actin is invariably present in all eukaryotic cells with a striking degree of conservation. It 
is also suggested to be one of the ancestral genes of the last common ancestor prokaryotes 
and eukaryotes shared (Erickson, 2007). Prokaryotic homologs of actin (MreB, FtsA, 
ParM) do have little sequence homology to eukaryotic actin, but they share a strikingly 
similar fold (Shaevitz and Gitai, 2010). Mammals and birds have six isoforms that arose by 
gene duplications, which share more than 93% sequence identity (Perrin and Ervasti, 
2010). The isoforms are expressed in a regulated and tissue specific manner and despite 
their extreme conservation, show divergent properties that contribute to the varying 
functions of actin in different tissues (Perrin and Ervasti, 2010). All α isoforms (αskeletal, 
αcardiac, αsmooth) and γcardiac actin are mainly expressed in the respective muscle tissues, 
whereas β and γ actin are expressed ubiquitously in muscle and nonmuscle cells. The 
isoforms (α, β, γ) differ only by subtle amino acid changes, most of them confined to the 
extreme N-terminus of the protein (Herman, 1993). The isoactins may differ in their 
binding affinities to certain actin binding proteins (ABPs) such as cofilin, thymosin β4 and 
profilin, show differential localization patterns within the same cell and differ in their 
polymerization rates under non-physiological conditions (reviewed in (Herman, 1993; 
Perrin and Ervasti, 2010)  
2.4.2 Structure of the actin monomer 
Actin is a single polypeptide chain of 375 amino acids that makes up a 42 kDa globular 
protein and shares a unique fold with other members of its ATPase superfamily: sugar 
kinases and Hsp70 (Bork et al., 1992). The protein has two major domains that are 
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connected to each other by a flexible hinge region. The domains are termed as small and 
large or outer and inner domains (according to their positions in an actin filament) 
respectively. These two domains are further divided into subdomains, which are 
historically referred as subdomains 1-4 (Figure 2-6). The hinge region between the 
domains creates two clefts that are essential to actin function: the nucleotide cleft and 
target-binding (hydrophobic) cleft (Dominguez and Holmes, 2011). The nucleotide cleft 
accommodates the adenine nucleotide (ATP or ADP) and the divalent cation (Mg++ in 
vivo), which in turn provides a further contact between the subdomains 2 and 4 
(Dominguez and Holmes, 2011). The smaller cleft between the subdomains 1 and 3 is 
lined with hydrophobic residues, which serve as a docking side for most of the actin 
binding proteins (ABPs) (Dominguez, 2004). The two clefts communicate with each other 
via conformational changes of the subdomains relative to each other, which is essential for 
the modulation of the nucleotide and ABP binding affinities. DNaseI is an exceptional 
ABP, which binds to a specific loop in the subdomain 2, D-loop (39-51), rather than the 
hydrophobic cleft (Dominguez and Holmes, 2011). 
2.4.3 The actin filament and regulation of polymerization 
Actin monomers can self assemble in a directional manner to form long filaments. An actin 
filament can be considered as two arrays of actin molecules (protofilaments) that wind 
around each other to form a right-handed helix with a long pitch (Alberts et al., 2007). 
Similar to the actin monomer (G-actin, globular actin) the resulting actin filaments (F-
actin) are polar in nature (Figure 2-6). The two ends of an actin filament polymerize at 
different rates: the fast growing end is termed as the plus (barbed) end and the slow 
growing end is called minus (pointed) end (Pollard, 1986). Polymerization, like 
crystallization, starts with energetically unfavorable nucleation step. Once a stable core is 
formed, filaments grow rapidly until equilibrium is reached between monomers and 
filaments. The free monomer concentration at this equilibrium is referred as the critical 
concentration (Cc). All actin monomers above this concentration polymerize into filaments 
(Carlier, 1990). 
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Figure 2-6 Structure of G-actin, profilactin and the actin filament 
A) Structure of the skeletal alpha actin monomer (G-actin) PDB-ID: 2A42 (actin-DNaseI complex)(Chereau et al., 2005). 
The bound nucleotide (ATP) and the cation (Ca++ here) are shown in red and green respectively. Hinge region, where the 
subdomains 1 and 3 connect, is shown in orange. DNase-I binding loop (D-loop) is shown in violet. The cleft between 
subdomains 2 and 4 is the nucleotide cleft, and this also constitutes the pointed (-) end of the actin monomer. The cleft 
opposite to the nucleotide cleft is the hydrophobic target binding cleft, where most ABPs bind actin. B) Structure of alpha 
actin profilin complex (also referred as profilactin) PDB-ID: 2PBD (Ferron et al., 2007). Profilin binds to the target 
binding cleft at the barbed end of an actin molecule. Note that the D-loop is disordered in this structure since it is not 
stabilized by DNaseI. C) Structure of the actin filament (F-actin) from the model with PDB-ID 3LUE(Galkin et al., 
2010). In this model, the F-actin filament is decorated with actin binding (CH1) domain of α-actinin, which binds to the 
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subdomains 1-2 near the D-loop. The CH1 domains, shown in gray, indicates the orientation and the twist of the actin 
monomers (each in different colors) within the filament. On the right, both ends of a filament are shown in close-up top 
views. 
 
Polymerization triggers conformational changes on the actin monomer, which increase its 
intrinsic ATPase activity. Nucleotide is rapidly hydrolyzed and inorganic phosphate is 
released at a much slower rate. The nucleotide state marks the age of an actin filament as 
the release of phosphate causes destabilization of the actin-actin interactions and structural 
changes in the filament (Carlier, 1990). Treadmilling, the assembly of new (ATP) subunits 
at the barbed end and simultaneous dissociation of old (ADP) subunits at the pointed end, 
occurs at sufficiently high monomer concentrations, as a result of the differences in the 
association kinetics at the two ends of a filament and irreversible ATP hydrolysis (Wegner, 
1982). Keeping monomeric actin concentration high enables the cell to rearrange the 
cytoskeleton in a very short time upon external stimuli. 
The actin Cc for polymerization depends on the bound nucleotide (CcATP < CcADP+Pi < 
CcADP), the nucleotide bound divalent cation (CcMg++< CcCa++) and the type and 
concentration of the ions in the solution (Kang et al., 2013). Salts and temperature lower 
the actin Cc, such that addition of potassium, magnesium (or calcium) and ATP will 
already initiate polymerization of an actin solution (Spudich and Watt, 1971; Wegner, 
1982). In vitro, actin Cc near physiological conditions are as low as  0.1 - 0.2 µM, whereas 
in vivo cellular monomeric actin concentration can reach 50-200 µM (Alberts et al., 2002). 
The cell invests considerable amount of resources to regulate the actin cytoskeleton 
dynamics. There are a myriad of actin binding proteins that are involved in functions such 
as keeping actin monomeric (profilin, cofilin, thymosin β4), filament nucleation and 
branching (formins, Arp2/3 complex), filament elongation at the barbed end (formins), 
capping of the filament ends (capping protein, CapZ, tropomodulin), filament 
severing/depolymerization (gelsolin, severin, cofilin), filament stabilization (tropomyosin), 
filament bundling/crosslinking (α-actinin, spectrin, dystrophin, utrophin) and motor 
proteins that move on actin filaments (myosins) (Pollard and Cooper, 1986; dos Remedios 
et al., 2003; Pollard and Borisy, 2003; Pollard and Cooper, 2009).  
The actin cytoskeleton is not only regulated by actin binding proteins, but also by a 
number of small molecules. Plants, fungi, bacteria and some marine organisms produce 
toxins that can act on the actin cytoskeleton. Some of these toxins bind to actin monomers 
and cause rapid actin depolymerization (Latrunculins, Cytochalasins, Swinholide A, etc), 
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some others bind to actin filaments and stabilize them (Phalloidin, Jasplakinolide, etc) 
(Allingham et al., 2006). These toxins are intensively used in actin research: cytochalasins 
and latrunculins as actin depolymerization drugs (Cooper, 1987; Morton et al., 2000), 
fluorescently labeled phalloidin for actin filament visualization (Wulf et al., 1979). 
2.4.3.1 Profilin 
Among all actin-binding proteins, profilin will be of special importance for this project. It 
is not only an important regulator of actin polymerization, but also is the cofactor for actin 
nuclear export. Profilin is a small (15 kDa) protein, which was first identified in a 1:1 
complex with actin as an inhibitor for DNaseI (Carlsson et al., 1976, 1977). Figure 2-6 
shows the crystal structure of profilactin complex. In mammals there are four isoforms of 
profilin, encoded by different genes either ubiquitously (profilin I) or in a tissue specific 
manner (profilin II – brain, profilin III,IV – testis) (Birbach, 2008). The first function 
attributed to profilin was inhibition of polymerization (Carlsson et al., 1977). Indeed, 
profilin is present in eukaryotic cells from protozoa through humans in varying but high 
concentrations (20-100uM) (dos Remedios et al., 2003; Dominguez and Holmes, 2011) 
and is responsible for a large portion of the monomeric actin pool. But a true sequestering 
factor for actin is thymosin β4 (Safer et al., 1991). Functions of profilin are much more 
diverse and complex. Profilin inhibits actin nucleation (Reichstein and Korn, 1979), 
catalyzes nucleotide exchange (Mockrin and Korn, 1980) and inhibits ATP hydrolysis on 
actin (Tobacman and Korn, 1982), promotes ATP-actin addition to the barbed end of actin 
filaments (Tilney et al., 1983). Profilin binds to Poly-L-proline sequences (Tanaka and 
Shibata, 1985), through which it is associated to formins like VASP (Ferron et al., 2007). 
Its high affinity to PIP2 makes profilin a likely mediator between the receptor tyrosine 
kinase signaling pathways and the cytoskeleton (Lassing and Lindberg, 1985). Last but not 
least, profilin is an essential binding partner for the nuclear export of actin (Stuven et al., 
2003). 
2.4.4 Nucleocytoplasmic distribution of actin 
Actin is a protein with prominent cytoplasmic functions. Together with microtubules, actin 
filaments (microfilaments) make up the cytoskeleton. In non-muscle cells they are 
organized in bundles and networks. The actin cytoskeleton shapes the cell, is essential for 
cytokinesis, provides cellular motility (lamellipodia, filopodia, pseudopodia) and forms the 
tracks for intracellular transport of macromolecules, vesicles, even organelles. The 
cytoskeleton is very dynamic and responds to a variety of intra- and extracellular stimuli. 
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In muscle cells, actin and actin motor protein myosin form the contractile bundles 
(myofibrils) together with several other ABPs, to provide force and motion. Here, the actin 
filaments are not nearly as dynamic as the cytoskeleton.  
Actin with its globular fold and 42 kDa molecular weight is at the limit of the passive 
diffusion barrier of the NPC (Mohr et al., 2009). Indeed, actin was shown to diffuse 
passively into the nucleus (De Robertis et al., 1978). Another route for actin into the 
nucleus is the breakdown of the nuclear envelope during mitosis, which causes an 
intermixing of the nuclear and cytoplasmic contents. More recently, an active nuclear 
import pathway for actin by Imp9 has been suggested (Dopie et al., 2012), but there is still 
no convincing biochemical data for this interaction. Despite the ability of actin to enter the 
nucleus, the predominant cytoplasmic localization of actin in vast majority of the cells 
indicates an active export mechanism. Actin was first claimed to be exported by CRM1 via 
two potential NESs (Wada et al., 1998). But in reality these suggested NESs correspond to 
rigid folds in the three dimensional structure of the protein, which would be inaccessible 
for CRM1 binding. Indeed, a couple of years later, a new NTR, exportin 6, was identified 
and shown to be the only responsible factor for actin nuclear export (Stuven et al., 2003). 
While the cytoplasmic functions of actin have been understood quite well, the presence 
and the role of actin in the nucleus have been debated in the field since a long time. First 
reports of nuclear actin in somatic cells (Ohnishi et al., 1964), and amphibian oocytes 
(Clark and Merriam, 1977) date back almost 50 years by now. While the nuclear actin 
network of amphibian oocytes is widely supported by further research; the presence, form 
and functions of actin in the somatic cell nuclei is still under heavy debate. There are 
various reports for actin being involved in nuclear functions such as transcriptional 
regulation by binding to RNA polymerases (Fomproix and Percipalle, 2004; Hofmann et 
al., 2004; Hu et al., 2004; Philimonenko et al., 2004), chromatin remodeling (Zhao et al., 
1998) and histone modification (Sjolinder et al., 2005). However, these studies fail to 
elucidate the molecular mechanisms of actin function in the mentioned complexes. A more 
convincing study shows that actin regulates the nuclear transport and the activity of the 
transcriptional activator MAL (Vartiainen et al., 2007).  
Even if actin is involved in nuclear functions, the form of actin (monomeric or 
filamentous) in the nucleus remains unsettled so far. To date, no phalloidin stainable 
filaments have been observed in the somatic nuclei (Hofmann and de Lanerolle, 2006), and 
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other observations with GFP-actin indicate an immobile pool of actin (McDonald et al., 
2006), which does not necessarily refer to filamentous actin as we know it. Even in the 
presence of the active export mechanism, not all actin molecules can be removed from the 
nucleus. The facilitated transport can function within the limits of the RanGTP gradient 
(1000 fold, (Gorlich et al., 2003)), hence the actin concentration in the nucleus is probably 
kept at 0.1-1% of cytoplasmic G-actin levels. Also, any actin molecule that is bound to 
other nuclear binding partners is out of the reach of Exportin 6. This residual amount of 
actin in the nucleus is sufficient to explain the regulatory functions that G-actin might be 
involved. However, it efficiently prevents the formation of the filaments similar to the 
cytoplasmic ones. 
2.4.5 Exportin 6-mediated actin nuclear export pathway  
Exportin 6 (Xpo6) is conserved in all vertebrates and insects and even in the evolutionary 
distant slime mold Dictyostelium discoideum; however, no Xpo6 has been identified in 
fungi, plants and in C. elegans (Stuven et al., 2003). BLAST analyses show that CRM1 is 
the closest relative of Xpo6 within the Imp-β superfamily of NTRs in terms of amino acid 
sequence. Xpo6 interacts with only a couple of functionally related proteins in a Ran 
dependent manner: β-actin, profilin, Mena, Vasp and mDia, which all are part of actin 
cytoskeleton (Stuven et al., 2003). From those, only actin and profilin are identified as the 
actual cargos. The identified export complex, Xpo6Ranβ-actinprofilin, is reported to 
have a 1:1:1:1 stoichiometry. Mena, Vasp and mDia are all members of the formin family, 
which bear proline-rich profilin binding sites (Holt and Koffer, 2001) and might be 
recruited to the export complex via the Poly-Pro binding pocket of profilin. The sequence 
conservation between Xpo6 orthologs is rather low compared with other NTRs. Zebrafish 
(D. rerio) Xpo6 is ~72% identical in amino acid sequence with the human protein, 
however the identity between Drosophila and human Xpo6 is as low as 20% (Stuven et al., 
2003). Despite the low conservation, the functionality across species is still conserved 
(Stuven et al., 2003). Xpo6 can export all human profilin isoforms (Stuven et al., 2003), β- 
γ- α- isoforms of actin and even actin from yeast (Bohnsack et al., 2006). 
The fact that Xpo6-mediated actin export is conserved in higher eukaryotes, indicates a 
selective pressure on keeping nuclear actin levels low in these organisms. There are 
however, some exceptions to the rule. Amphibian oocyes, as mentioned, accumulate large 
amounts of phalloidin stainable actin in their nuclei (Roeder and Gard, 1994). It was found 
that they maintain this nuclear actin pool by specifically blocking Xpo6 expression at 
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translational level, which is only relieved during meiotic maturation (Bohnsack et al., 
2006). The inhibition of actin nuclear export is essential for the stabilization of the giant 
nuclei (400µm in diameter) of this cell type, as the microinjection of exogenous Xpo6 to 
the Xenopus oocyte nuclei caused immediate export of all actin and rendered the nuclei 
very fragile (Bohnsack et al., 2006). It is now known that there is an actin nucleoskeleton 
in Xenopus oocytes, whose function is not only the mechanical stabilization of the nuclei, 
but also proper segregation of the chromosomes and polar body extrusion during meiosis 
(Samwer et al., 2013). 
When Xpo6 is silenced in Drosophila Schneider cells, intranuclear accumulation of rod-
shaped actin aggregates was observed (Stuven et al., 2003). Also, a lethal Drosophila 
mutant identified 25 years ago (Perrimon et al., 1989) turned out to have a defective Xpo6 
gene. Recently, a genome-wide morphology RNAi screen has been performed in 
Drosophila S2R+ cells in parallel to a more focused RNAi screen in HeLa cells for all 
known actin regulatory proteins (Rohn et al., 2011). It has been shown that knockdown of 
Xpo6 and Drosophila profilin (chic) leads to the formation of phalloidin stainable actin 
rods within the nucleus. Several other studies showed that actin accumulation occurs as a 
result of the disruptions to the actin nuclear export pathway. In senescent cells, where 
RanGTP gradient is disrupted, nuclear actin accumulation is commonly seen (Park et al., 
2011). ATP depletion (and concomitant GTP depletion) has caused rod-like actin 
accumulation in the nucleus of mouse cell lines (Domazetovska et al., 2007). DMSO 
treatment in amoeba, Dictyostelium and in HeLa cells (Fukui and Katsumaru, 1979; 
Osborn and Weber, 1980; Sanger et al., 1980), which probably breaks down the 
permeability barrier of the NPC (Ribbeck and Gorlich, 2002), results similarly in actin 
bundles in the nucleus. Accumulation of actin in these cases is only plausible if the main 
route of actin into the nucleus is passive diffusion. After the depletion of the RanGTP 
gradient, which is also an eventual result of the permeability barrier breakdown, all Ran-
dependent nucleocytoplasmic transport comes to a stall. With no active nuclear export 
mechanism to pump out, actin accumulates in the nucleus.  
2.4.6 Intranuclear rod myopathy 
A special case of nuclear actin accumulation is seen in patients suffering from intranuclear 
rod myopathies (IRM). IRM are muscle diseases that are associated with muscle weakness, 
hypotonia, hyporeflexia, a high-arched palate and autonomic dysfunctions, while the onset 
and the severity of the disease varies between patients; in many cases lethal in the early 
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stages of life (Hutchinson et al., 2006; Kaimaktchiev et al., 2006; Chou et al., 2013; 
Nowak et al., 2013). IRM is characterized by the accumulation of rod-like actin structures 
in the nuclei of the muscle cells (Goebel and Warlo, 1997) (Figure 2-7). Each identified 
case of IRM so far revealed a mutation in the skeletal α-actin gene (ACTA1) (Feng and 
Marston, 2009). To date there are roughly 180 known mutations of the human ACTA1 gene 
(Laing et al., 2009). These mutations cause a wide range of muscle abnormalities, 
collectively referred as myopathies: nemaline myopathy (NM), actin myopathy (AM), core 
myopathy (CM), intranuclear rod myopathy (IRM), congenital fiber type disproportion 
(CFTD) (Feng and Marston, 2009; Laing et al., 2009). 13 mutations, causing amino acid 
changes in 12 different positions in ACTA1 have been associated with IRM so far (Goebel 
and Warlo, 1997; Laing et al., 2009). Where some of the mutations localize around the 
hinge region (Figure 2-7), it is hard to associate the mutations with the loss of a particular 
function of the molecule.  
 
Figure 2-7 Intranuclear rod myopathy 
A) Intranuclear rod caused by V165M mutation (Sparrow et al., 2003). B) Muscle biopsy from the left anterior tibial 
muscle, Gomori trichome staining, intranuclear rods are shown with arrows (Arai et al., 2009). C-D) muscle biopsy of a 
patient with V165M mutation c) electron micrograph; the intranuclear rod is indicated with a white arrowhead. d) 
hematoxylin-eosin staining; all nuclei contain actin rods. (Hutchinson et al., 2006) E) 13 known IRM mutations 
illustrated on the monomeric alpha actin (PDB-ID: 2A42). Note that most of the mutations localize near the hinge region.  
 
Why these mutations lead to an exclusive nuclear accumulation in the first place still 
remains to be elucidated. There are several hypotheses on the mechanisms that lead to 
nuclear accumulation of IRM mutants, some of which are based on flawed arguments. 
Several studies hypothesized that some IRM mutations interfere with the so-called NESs 
of actin, impairing the nuclear export (Ilkovski et al., 2004; Kaimaktchiev et al., 2006; 
Ravenscroft et al., 2011), others hypothesized an increased trafficking into the nucleus 
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properties due to the mutations in the hinge region (Sparrow et al., 2003; Ravenscroft et 
al., 2011). Based on the conserved nuclear actin export pathway, we hypothesize that at 
least some of these mutations might compromise Xpo6 binding of actin, leading to a 
nuclear accumulation and consequent rod formation.  
There are many open questions that need to be answered concerning the nucleocytoplasmic 
transport of actin. How does Xpo6 interact with its cargo on molecular level? Does the 
cargo and Ran interact in the complex? What kind of conformational changes occur in 
Xpo6 between the cargo-bound and free forms? Is profilin making contacts with Xpo6, or 
how exactly does it contribute to the recognition of actin by Xpo6? Are any of the IRM 
mutations in the Xpo6-actin binding interface? How else can they interfere with the Xpo6-
actin interaction? Can we design any profilin or Xpo6 mutants that can recognize IRM 
actins? These questions can only be addressed with structural information of the actin 
export complex at atomic resolution. For this reason, we aspired to structurally 
characterize the actin nuclear export complex by X-ray crystallography. We want to 
understand the dynamics of cargo recognition by Xpo6, the details of actin 
nucleocytoplasmic shuttling, and eventually elucidate the molecular mechanisms leading 
to IRM.  
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3 Results 
Crystallization of a macromolecule requires sample preparations of highest purity and 
homogeneity. Once this is achieved, one has to identify the conditions for crystallization 
and diffraction at an optimum resolution. This may represent a very narrow window in a 
vast amount of possible conditions. In this project, we set out to crystallize a four-
component complex (Xpo6RanGTPactinprofilin) with a size of 200 kDa. This certainly 
is a challenge on its own. There were however, other unanticipated obstacles we had to 
overcome on the way towards successful crystallization. First challenge was the low 
affinity of skeletal alpha actin for the other components of the complex. Later, we found 
out that the export complex was extremely salt sensitive in vitro. Also, the recombinant 
expression and purification of individual proteins, especially Xpo6, had to be optimized for 
better yield and purity. But the expression/purification optimizations will not be discussed 
here for the sake of brevity. The latest purification conditions are described in materials 
and methods section. In this section, we will rather focus on the formation of the export 
complex and sub-complexes in vitro, the biochemical properties of the export complex and 
the crystallization trials for the Xpo6RanGTP complex, the free Xpo6 and the actin 
nuclear export complex.  
3.1 The actin isoforms differ in their affinity for the complex 
3.1.1 First attempts with α-actin from skeletal muscle 
In our first attempts to assemble the export complex, we have used purified, tag-free 
proteins. Actin was purified from rabbit skeletal muscle as described in section 6.2.3. We 
simply mixed them in near stoichiometric ratios and incubated them in the cold room for 
1.5 hours. Actin, profilin and Ran were added in 1.2 fold molar excess over Xpo6, in order 
to be able to saturate Xpo6. Later, the solution was exchanged to a low ionic strength 
buffer (50 mM Tris pH 7.5, 50 mM NaCl, 0.5 mM MgCl2, 5 mM DTT), centrifuged and 
applied to Superdex 200 10/30 gel filtration column, equilibrated with the same buffer. 
Figure 3-1 shows the gel filtration profile and the SDS PAGE analysis of the fractions. It is 
seen that the proteins indeed form a complex, and run together. However, the second most 
prominent finding is that the profilin is only weakly associated to the complex. By 
comparing the band intensities for Ran and actin, one can realize that also the association 
of actin to the complex is sub-stoichiometric. Profilin might be dissociating from the 
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complex during the gel filtration, or there might be a pool that doesn’t associate with actin 
and the complex to start with.  
 
Figure 3-1 Export complex formation with alpha actin 
A) The size exclusion chromatogram of the export complex on SD200 10/30 column equilibrated with 50 mM Tris pH 
7.5, 50 mM NaCl, 0.5 mM MgCl2, 5 mM DTT. Y-axis shows the UV absorbance at 280nm, X-axis shows the elution 
volume. B) Fractions of the gel filtration in (A) on a gradient SDS polyacrylamide gel. See text for experimental details. 
 
Free actin above the critical monomer concentration can polymerize into filaments under 
suitable ionic conditions (Wegner, 1982; Carlier, 1990). Equal amounts of actin and 
profilin were present in the initial mixture and a fraction of profilin did not bind actin and 
eluted from the column as monomers. Since there was not an additional peak for actin in 
the chromatogram, the unbound actin most likely polymerized and was removed by 
centrifugation before gel filtration. 
In our later experiments, we tried to improve the initial complex, by varying several 
parameters. We increased the actin and profilin concentrations in the complex formation, 
we compared actin purified rabbit and chicken skeletal muscle. We realized in our 
experiments that some components of the actin export complex have buffer requirements 
that are not compatible with each other. We observed a tendency of Ran to aggregate in 
low salt buffers, when it is not bound by NTRs. Actin on the other hand, tends to 
polymerize at salt concentrations of 50 mM (Spudich and Watt, 1971), if it is not kept 
monomeric by profilin. Salt concentrations that are too low for unbound Ran are already 
too high for actin to be monomeric, which represents a major dilemma for the complex 
formation. We used low salt concentrations (20mM) and cytochalasin B (CytB, 10µM) in 
the reaction in order to prevent actin polymerization and improve complex formation. We 
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Neither could we improve the complex stability by varying concentrations of the 
components or inhibition of actin polymerization. 
3.1.2 Non-muscle actins form a more stable complex with profilin  
The affinity problems with α actin led us to alternative sources for actin. In the literature, 
there are several studies showing that skeletal (α) actin has less affinity towards profilin 
than non-muscle actin isoforms (β/γ) (Larsson and Lindberg, 1988; Ohshima et al., 1989; 
Vinson et al., 1998; Kinosian et al., 2000). We therefore decided to use HeLa cytoplasmic 
extract as a source for non-muscle actin. We first analyzed whether a stable profilactin 
complex could be formed with non-muscle actin. In a parallel experiment, we tested 
purified α actin (chicken) or cytoplasmic HeLa extract as an actin source. Profilin with an 
N-terminal His-tag was used to pull actin from the solution. Actin was supplied in excess 
in both setups. Proteins were incubated in the presence of 5 mM EDTA and 5 µM CytB for 
1 h in cold room, and then bound to Ni-matrix for 2 h in a low salt buffer (10 mM Tris 7.5, 
20 mM NaCl, 1mM DTT) in the presence of 5 mM imidazole to reduce unspecific binding 
to the matrix. The unbound proteins were removed, and the bound profilin and profilin-
bound actin were eluted by the cleavage of the His-tag with SumoStar protease. Later the 
still Ni-bound fraction was post-eluted with imidazole. Figure 3-2 shows the result of the 
experiment. It is seen that with the same amount of profilin, more actin was pulled from 
the HeLa cytoplasmic extract compared to purified α actin.  
Our experiment also represents a very elegant one-step method for purification of 
cytoplasmic actin and profilactin. Muscle actin can be purified in high-yield with a 
relatively straightforward method that relies on multiple rounds of polymerization and 
depolymerization (Spudich and Watt, 1971).  However, the protocols for non-muscle actin 
purification have been very cumbersome and low in yield in comparison to muscle actin 
purification. Multiple purification steps such as Cγ alumina gel, DEAE chromatography, 
hydroxyapatite chromatography, ammonium sulfate precipitation and gel filtration had to 
be combined for the optimum purity (Lindberg, 1967; Carlsson et al., 1976; Gordon et al., 
1976; Carlsson et al., 1977). Here we show that highly pure non-muscle actin and 
profilactin can be isolated from HeLa cytoplasmic extract in a one-step protocol. This 
method can also be used with tissue extracts other than HeLa cells. 
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Figure 3-2 Profilactin with muscle and non-muscle actin isoforms 
Formation of profilactin complexes with muscle and non-muscle actin isoforms. 5.2 nmol His-tagged profilin was 
incubated with 13nmol α actin or 500 µL HeLa S10 extract. Binding was performed in 10 mM Tris 7.5, 20 mM NaCl, 
1mM DTT. Profilin was immobilized to Ni-matrix and the bound proteins were eluted with SumoStar protease cleavage 
of the His-tag. Input: actin source and His-tagged profilin, unbound: flow through of unbound proteins from Ni-matrix, 
protease elution: SumoStar elution of profilin and profilin bound actin, post-elution: imidazole elution of Ni- bound 
proteins.  
  
We then subjected these profilactin complexes to gel filtration and compared their running 
profiles. The gel filtration was performed in the same buffer, where the complexes have 
been formed, but lacked EDTA and CytB. The difference between the actin isoforms 
became more obvious here. It was seen that almost all α actin dissociated from profilin 
during or before gel filtration and a large portion eluted from the column as high molecular 
weight assemblies (Figure 3-3). Whether these are true actin filaments or simply 
aggregates is not clear. On the other hand, profilactin formed with cytoplasmic actin 
remained stable during gel filtration. The free profilin eluting at the end of the column is 
not due to dissociation of the complex, but rather from incomplete saturation of the initial 
profilin in the binding reaction. With this, we could confirm the previous reports about the 
lower affinity of α actin towards profilin compared with β/γ actin. This result also 
indicated that cytoplasmic actin is indeed a better substrate for the formation of an export 
complex in vitro. From this point on, we have used HeLa cytoplasmic extract as an actin 
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Figure 3-3 A stable profilactin complex can be formed with cytoplasmic actin 
The upper panel shows the gel filtration chromatograms of profilactin complexes with α actin and cytoplasmic (β/γ) actin 
on SD200 10/30 column equilibrated with 10 mM Tris 7.5, 20 mM NaCl, 1mM DTT. Y-axis shows the UV absorbance 
at 280nm, X-axis shows the elution volume. Green represents the chromatogram with α actin; blue represents the 
chromatogram with β/γ actin. Lower panel shows the analysis of the gel filtration fractions via SDS PAGE. Left gel 
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3.2 Screening for optimal conditions for the actin nuclear export 
complex  
In order to assemble a stable actin export complex, the optimal conditions have to be 
determined first. For screening a variety of buffer and salt conditions, we designed a 
phenyl sepharose (PS) based binding assay. Phenyl sepharose binds to NTRs with high 
affinity (Ribbeck and Gorlich, 2002), and the experimental setup for PS based binding 
assay is straightforward. We used purified, tag-free Xpo6 and RanGTP, and used HeLa 
cytoplasmic extract as a source for actin and profilin. The concentrations of the 
components were titrated to come to a saturation of Xpo6. In this assay, the components 
were mixed and diluted in a 500 µL binding reaction with the buffer condition to be tested. 
PS matrix was included in the binding reaction for 3 h, and after the removal of unbound 
material, bound proteins were eluted with SDS buffer. The specificity of complex 
formation on PS matrix was also confirmed with +/- Ran controls (Figure 3-4). While 
screening for the effects of salt on the complex formation, we found that with increasing 
salt concentration, less profilactin was bound to Xpo6. At 300 mM NaCl concentration, the 
loss of binding became more drastic. 
 
Figure 3-4 Effect of salt concentration on complex formation 
50 µL HeLa S10 cytoplasmic extract was incubated with 0.25 nmol tag-free Xpo6 and 0.5 nmol tag-free RanGTP(5-
180)Q69L in indicated buffers. Xpo6 was immobilized to 10 µL phenyl sepharose (PS) matrix. The unbound proteins 
were washed and the bound proteins were eluted with SDS buffer. A) Profilactin from HeLa cytoplasmic extract binds to 
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profilactin binding to Xpo6 on phenyl sepharose matrix. B). Binding conditions were varied between 0-300 mM NaCl 
and Tris pH 7.0-8.0. The SDS elution from the PS matrix is shown. 
 
Next, we screened for different buffers and pH for their effect on complex formation. We 
couldn’t detect any preference for a certain buffer and pH (Figure 3-5). PS based complex 
formation was easy to perform, but the complex could only be removed from the matrix by 
denaturation. We therefore had to transfer the findings of PS experiments to another setup. 
We decided to proceed with low concentrations of buffer and salt because of our ultimate 
aim of crystallization. 
 
Figure 3-5 Effect of buffer ions and pH on complex formation 
RanGTP dependent binding of profilactin to Xpo6 immobilized on phenyl sepharose matrix. Experimental setup was 
identical with Figure 3-4. Different buffer ions (Tris, HEPES, potassium phosphate (K-PO4), 10 mM each) adjusted to 
various pH values were tested. NaCl was kept constant at 50 mM for all experiments. Individual bands are labeled. No 
visible effect could be detected. 
3.3 Xpo6 and RanGTP can form a stable dimeric complex in vitro 
In our complex formation trials, we observed that RanGTP always migrated together with 
Xpo6 in gel filtration, even when actin was not incorporated. This is rather unusual for 
exportins, which usually have mediocre affinity for RanGTP in the absence of a cargo 
(Fornerod et al., 1997; Kutay et al., 1997). This brought up the question whether Xpo6 and 
Ran can form a stable dimer in the absence of cargo. We have used His tagged RanGTP 
and tag-free Xpo6 for complex formation. The complex was immobilized on Ni-matrix via 
the N-terminal His-tag of RanGTP and eluted with protease digestion of the tag. Xpo6 and 
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remained stable as well in low salt buffer (10 mM Tris 7.0, 10 mM NaCl, 2 mM DTT) 
used in gel filtration (Figure 3-6). This also showed that RanGTP remains stable in low salt 
concentrations, when it is bound by Xpo6. 
 
Figure 3-6 Xpo6 and RanGTP can form a stable complex in vitro 
200 nmol His-tagged RanGTP(5-180) and tag-free Xpo6 were incubated and immobilized on Ni-matrix. The bound 
fraction was eluted from the column by Sumo cleavage of the His-tag of RanGTP. This fraction was concentrated and 
further purified with gel filtration. A) The size exclusion chromatogram for Xpo6RanGTP complex on SD200 16/60 
column equilibrated with 10 mM Tris 7.0, 10 mM NaCl, 2 mM DTT. Y-axis shows the UV absorbance at 280nm, X-axis 
shows the elution volume. B) Fractions of the indicated range from gel filtration in (A) on a gradient SDS polyacrylamide 
gel. Standard indicates a manually mixed solution of Xpo6 and RanGTP in 1:1 molar ratio. It was loaded for 
stoichiometry comparison with the peak fractions.  
 
3.4 Actin export complex can be formed via two stable sub-
complexes 
We have used the approach to form the tetrameric export complex via two sub-complexes: 
profilactin and Xpo6RanGTP. We have previously shown that these sub-complexes were 
stable in gel filtration in low salt buffers. This approach enabled us to overcome the 
discrepancy between the buffer conditions required for free actin and free RanGTP. Free 
actin tends to polymerize in high salt conditions, whereas free RanGTP precipitates in low 
salt conditions. As shown above, RanGTP forms a dimeric complex with Xpo6, which 
remains stable in salt concentrations as low as 10 mM. We have incubated pre-formed 
complexes of profilactin and Xpo6RanGTP in this low salt buffer overnight in cold room. 
We have added the profilactin complex in excess, in order to be able to saturate the 
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tetrameric complex can be formed with this method. However, the excess profilactin in the 
mixture can not be separated from the export complex properly. There is also minor 
dissociation in profilactin such that free actin (as high molecular weight assemblies) and 
free profilin is seen in the chromatogram. For better purity, we took the peak fraction of 
the first gel filtration and subjected to gel filtration once more. We obtained a single peak 
and the analysis of the fractions showed that a stoichiometric complex could be formed 
with this method.  
 
Figure 3-7 Formation of the actin nuclear export complex 
Profilactin and Xpo6RanGTP complexes in 10 mM Tris 7.0, 10 mM NaCl, 2 mM DTT were mixed in near 
stoichiometric ratios (profilactin in excess) and incubated overnight in the cold room. The mixture was concentrated and 
applied to SD200 10/30 column equilibrated with the same buffer. The peak fractions of the first chromatogram were 
taken, concentrated and subjected to gel filtration again. A) The size exclusion chromatogram for the profilactin and 
Xpo6RanGTP mix on SD200 10/30 column. Y-axis shows the UV absorbance at 280nm, X-axis shows the elution 
volume. B) Fractions of the indicated range from gel filtration in (A) on a gradient SDS polyacrylamide gel. C) The size 
exclusion chromatogram for the peak fraction from B (3rd and 4th fractions in the gel) on SD200 10/30 column. Y-axis 
shows the UV absorbance at 280nm, X-axis shows the elution volume. D) Fractions of the indicated range from gel 
filtration in (C) on a gradient SDS polyacrylamide gel. Standard indicates a manually mixed solution of Xpo6, RanGTP, 
α actin and profilin in equimolar ratio. It was loaded in varying amounts for stoichiometry comparison with the peak 
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3.5 Actin nuclear export complex is sensitive to ionic strength 
We wanted to test how much salt the actin export complex can tolerate. The PS 
experiments indicated that NaCl concentrations of 300 mM significantly impair complex 
formation. The salt sensitivity can be a problem for crystallization screens, since most 
crystallization conditions contain salts. Export complex was formed via two sub-
complexes in 10 mM Tris 7.0, 10 mM NaCl, 1 mM DTT as described in section 3.4. The 
peak fraction from the first gel filtration was taken, concentrated and divided into two. One 
aliquot remained in the low salt buffer, whereas the other aliquot was brought to 100 mM 
NaCl concentration. After 1 h incubation, the peak fractions were run on gel filtration in 
their respective buffer conditions. Figure 3-8 shows the results of the second gel filtration. 
The effects were striking. Increased salt concentration in one aliquot completely 
dissociated the pre-formed complex, such that two peaks with two sub-complexes were 
observed. In the control aliquot, complex remained mostly stable. There was a slight 
tailing of the peak in the gel filtration, which was partly due to the dissociation on the gel 
filtration and partly due to inhomogeneous peak fraction sampling of the first gel filtration. 
The complete dissociation of the complex at 100 mM NaCl was unexpected, considering 
the results of the phenyl sepharose experiments. In order to confirm the new findings, we 
designed a binding experiment on Ni-matrix. Either His-tagged profilin or His-tagged 
Xpo6 was used for the immobilization of the complex and different ionic conditions were 
tested. HeLa lysate and profilin were pre-mixed and incubated, to which pre-mixed Xpo6 
and RanGTP were added. 50 µL HeLa cytoplasmic extract, 1 µM profilin (tagged or 
untagged), 1 µM Xpo6 (tagged or untagged) and 1.2 µM RanGTP were used in a 500 µL 
binding reaction. Low and high salt conditions (10 to 100 mM NaCl) were prepared in 10 
and 50 mM Tris buffer pH 7.5. The immobilized and bound proteins were eluted with 
protease cleavage of the N-terminal tags. 
The results (Figure 3-9) confirmed the complex dissociation on gel filtration, and were 
dramatically different than PS experiments. The presence of 100 mM NaCl almost 
completely abolished complex formation. Not only NaCl, but also increasing buffer 
concentration affected complex formation negatively, as judged by the further loss of 
binding in 50 mM Tris conditions. The results were identical for complexes immobilized 
on profilin and Xpo6. Another interesting observation was that not only Xpo6RanGTP, 
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but also profilactin sub-complex remained stable in the tried conditions, meaning that it is 
the interface of these two sub-complexes that is sensitive to ionic conditions. 
 
Figure 3-8 Increasing salt concentration dissociates a pre-formed actin export complex 
Export complex was formed as described in Figure 3-7. The peak fraction of the first gel filtration was collected, split 
into two aliquots, and NaCl concentration in one aliquot has been increased to 100mM. The aliquots were run on gel 
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filtration equilibrated with their respective buffers after 1 h incubation. The upper panel shows the gel filtration 
chromatograms of actin export complexes incubated in different salt concentrations. Y-axis shows the UV absorbance at 
280nm, X-axis shows the elution volume. Green represents the chromatogram with low salt condition; blue represents the 
chromatogram with high salt condition. Lower panel shows the analysis of the gel filtration fractions via SDS PAGE. 
Left gel shows the fractions of the low salt complex, right gel shows the fractions of the high salt complex.  
 
 
Figure 3-9 Formation of the actin nuclear export complex is salt sensitive 
His-tagged Profilin or His-tagged Xpo6 were used to immobilize the export complex on Ni-matrix. 50 µL HeLa extract, 
0.5 nmol Profilin 0.5 nmol Xpo6 and 0.6 nmol RanGTP were used. Varying NaCl (10 to 100 mM) and buffer (Tris pH 
7.5 10-50mM) concentrations were used during binding, to test the effect on complex formation. The complexes were 
bound to Ni-matrix via the N-terminal tags of profilin or Xpo6, which were eluted by the SumoStar cleavage of the N-
terminal tags. The lanes on the left show the SumoStar elution of the complexes immobilized on profilin, the lanes on the 
left on Xpo6. Individual protein bands are labeled.  
 
3.5.1 The ionic species in the solution affect the export complex formation 
Latest results indicated that phenyl sepharose might be stabilizing the complex and 
masking the effect of salt on the complex formation. To be able to screen for optimal 
conditions for the complex formation, we performed the salt and buffer screens on Ni-
matrix. 0.5 µM Profilin, 50 µL HeLa cytoplasmic extract, 1 µM Xpo6 and 1.2 µM 
RanGTP were used in a 500 µL binding reaction. Profilactin was formed and immobilized 
on Ni-matrix in a low salt buffer (10 mM Tris pH 7.5, 10 mM NaCl, 1 mM DTT). The 
unbound proteins were removed. The pre-incubated Xpo6RanGTP was added to the 
matrix in 500 µL of the buffer condition to be tested. After 3 h incubation, the unbound 
proteins were removed, and the complex was eluted from the matrix by protease cleavage 
of profilin’s N-terminal tag. Low (10 mM) and slightly higher (50 mM) concentrations of 
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(potassium acetate, abbreviated as KAc) salts were tested. The “high” salt concentration 
was kept at 50 mM in order to be able to detect subtle differences. The buffer was kept 
constant at 10 mM Tris pH 7.5. It was also tested whether the addition of glycerol (5%) 
improved the complex stability. A slight reduction in the bound Xpo6 and RanGTP 
amount was detected for 50 mM salt conditions for NaCl, KCl and KAc. For NaAc, this 
loss of binding was not visible. No difference was observed upon addition of glycerol 
(Figure 3-10, A).  
 
Figure 3-10 The ionic species in the buffer have an effect on the complex formation 
Experimental setup was same as Figure 3-9. Here, the complex was immobilized on Ni-matrix via the N-terminal His-
tag of profilin. Salt conditions were varied to test their effect on complex formation. A) sodium chloride (NaCl), 
potassium chloride (KCl), sodium acetate (NaAc) and potassium acetate (KAc) salts were used at 10 mM and 50 mM 
concentrations. +/- 5% Glycerol was tested for each condition. 10 mM Tris pH 7.5 was kept constant for all reactions. 
The amount of bound Xpo6RanGTP indicated the stability of the complex in that condition. B) Effects of sodium 
chloride and sodium acetate on complex formation were compared at 10mM and 50 mM concentrations. +/- 5% Glycerol 
was tested for each condition. 10 mM Tris pH 7.5 was kept constant for all reactions.  
 
Since the difference between NaAc and other salts was not very dramatic, another binding 
assay was performed with higher salt concentrations. NaCl and NaAc salts were compared 
at 10 and 100 mM concentrations, while 10 mM Tris pH 7.5 was kept constant. In parallel, 
the addition of 2mM Mg(C2H3O2)2 (Magnesium acetate, abbreviated MgAc) was tested for 
its effects on complex formation. The binding assay was performed as described above. 
The differences between NaCl and NaAc were more obvious in this setup (Figure 3-10, B). 
At 100 mM concentration, NaCl almost completely inhibited complex formation. At 100 
mM NaAc, the binding was impaired as well, but the loss of binding was about 50 %. It 
was obvious that NaAc was better tolerated than NaCl by the actin export complex. No 
significant effect of MgAc was observed, but we decided to use it in the complex 
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formation, because both actin and RanGTP bind divalent cations (Mg++) to stabilize their 
nucleotide. 
Different buffers in varying pH values were tested on PS matrix, and no effect was 
observed. We repeated this experiment on Ni-matrix (as described above) and obtained 
results that were different than the initial ones (Figure 3-11). The experiment showed the 
variation in pH was well tolerated in Tris and HEPES(/KOH) buffers. But the complex was 
less stable in potassium phosphate (K-PO4) buffer and the stability showed a strong 
dependency on the pH. In K-PO4 pH 6.5 the binding of Xpo6 and RanGTP to profilactin 
was the weakest, and it gradually increased with the increasing pH. This was an interesting 
observation since the ionic strength of a pH 8.0 K-PO4 buffer is higher than that of a pH 
6.5 K-PO4 buffer. For further experiments we decided to continue using low 
concentrations of Tris pH 7.5 buffer. 
 
Figure 3-11 pH and buffer ions have an effect on complex formation 
The effect of different buffer ions and pH on complex formation was tested in a binding assay. Experimental setup was 
identical as in Figure 3-10. 10 mM of Tris, HEPES, and potassium phosphate (K-PO4) adjusted to the indicated pH 
values were tested. NaAc was kept constant at 50 mM for all experiments. Individual bands are labeled. Complex 
stability in the tested condition was judged by the amount of Xpo6RanGTP bound to profilactin. In K-PO4 buffers, the 
complex was less stable and the effect was pH dependent 
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3.6 Improving the strategy for the actin nuclear export complex 
formation 
We showed that the actin export complex could be formed via two sub-complexes in low 
salt conditions. However, the protocol was very long and cumbersome, including 4 gel 
filtration steps: one for each of the sub-complexes and two consecutive gel filtrations for 
the tetrameric complex. We therefore used a simpler protocol for the preparative scale 
purifications of the actin export complex, which were used later for the crystallization 
trials. This protocol was also employed in small scale for the binding assays: His-tagged 
profilin was incubated with HeLa cytoplasmic extract and immobilized on Ni-matrix. After 
washing the unbound material, pre-incubated Xpo6 and RanGTP were added to the matrix 
in excess, in low salt conditions, instead of the elution of profilactin. This second 
incubation allowed the formation of a tetrameric complex, which was still immobilized on 
the Ni-matrix. The unbound proteins were removed and the export complex was eluted 
with protease cleavage of the N-terminal tag of profilin. We could scale up this protocol 
for preparative purification of the complex for crystallization. Figure 3-12 shows the 
preparation steps of the export complex. We optimized our “complex buffer” relying on 
the previous experiments: 10 mM Tris pH 7.5, 20 mM NaAc (pH adjusted to 7.5), 2 mM 
MgAc, 1 mM DTT. 5mM imidazole was added to the buffers to reduce unspecific binding 
to Ni-matrix. We have seen that more Xpo6RanGTP was bound to profilactin with longer 
incubation times. So for the large-scale preparation we have incubated Xpo6RanGTP 
over night in cold room with profilactin bound to Ni-matrix. The complex was eluted from 
the matrix with protease cleavage of the N-terminal tag of profilin.  The complex was 
concentrated and applied to a gel filtration column (SD200 16/60) equilibrated with the 
complex buffer. Figure 3-13 shows the gel filtration profile of the actin export complex 
and the SDS-PAGE analysis of the fractions.  
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Figure 3-12 Purification of the actin nuclear export complex in large scale for crystallization 
Purification steps of the human actin nuclear export complex. HeLa cytoplasmic extract (S10) was incubated with N-
terminally tagged profilin, which is then immobilized to Ni-matrix. The unbound matrial was removed, and the matrix 
was washed with buffer to remove contaminants. Pre-incubated Xpo6 and RanGTP in excess over profilin were added to 
the matrix, and incubated overnight. The unbound proteins were removed. The complex was eluted by the cleavage of 
profilins N-terminal tag with SumoStar protease. Note that the complex purified with this strategy is already highly pure 
as judged by the SDS PAGE analysis. 
 
 
Figure 3-13 Gel filtration of the actin nuclear export complex 
A) The size exclusion chromatogram for the actin export complex on SD200 16/60 column. Y-axis shows the UV 
absorbance at 280nm, X-axis shows the elution volume. B) Fractions of the indicated range from gel filtration in (A) on a 
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As seen in the figure, the complex remains stable on the column and elutes as a symmetric 
peak, except for the shoulder to the right side of the peak. When the fractions were 
analyzed, it was seen that the shoulder consists of a small amount of free profilactin. This 
probably is a result of incomplete saturation of profilactin with Xpo6RanGTP, rather than 
dissociation on the column. 
We have subjected the purified complex to multi angle light scattering (MALS) analysis. 
Using MALS one can measure the absolute molecular weight of particles. The principles 
of the method are described in (Wyatt, 1993) and briefly explained in 6.2.9. MALS is also 
employed for the determination of stoichiometry of protein complexes (Mogridge, 2004). 
Our MALS system is coupled to gel filtration, such that analysis can be restricted to 
individual peaks on the gel filtration. The purified complex eluted as a single peak with a 
tailing towards the right side (Figure 3-14). The analysis showed the average molecular 
weight of the indicated peak as 177 kDa. However, the expected molecular weight of the 
actin nuclear export complex is 205 kDa (128 kDa (Xpo6) + 42kDa (actin) + 20 kDa 
(RanQ69L(5-180)) + 15 kDa profilin). The difference between the expected and the 
calculated molecular weight is 28 kDa, which corresponds to the half of the molecular 
weight of profilactin (57 kDa). This is an interesting finding and indicates that there might 
be a dissociation of the sub-complexes on the gel filtration, resulting in an inhomogeneous 
population where also cargo-free Xpo6RanGTP is present. 
 
Figure 3-14 Molecular weight analysis of the actin nuclear export complex with MALS 
A) The gel filtration profile of the actin export complex for MALS analysis. The peak area for molecular weight 
calculations is shaded gray. Concentration of the sample is measured by UV absorption (green) and refractive index 
(blue). Scattered light by the eluting particles is shown in pink. Note the tailing of the peak towards the right side. B) The 
distribution of the calculated molecular weights (average 177 kDa) within the selected peak area. A straight line indicates 
a homogenous mass distribution throughout the selected peak area. The curvature of the line possibly results from an 
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3.7 Topological analysis of the actin nuclear export complex 
We tried to derive the topology of the actin export complex by testing the accessibility of 
the cargo from different sites. Actin is very well mapped for its interactions with other 
actin binding proteins and small molecules (dos Remedios et al., 2003; Dominguez, 2004; 
Dominguez and Holmes, 2011). By analyzing the accessibility of certain binding sites on 
profilactin molecule, we can infer how Xpo6 might interact with profilactin. One site for 
testing the accessibility is the Poly-L-Proline binding cleft of profilin. This site is localized 
directly opposite to the actin-binding surface, in a groove created by the closely positioned 
N- and C-terminal helices of profilin (Figure 4-1 and (Ferron et al., 2007)). Most ABPs 
(cofilin, gelsolin, ciboulot, vitamin D binding protein, MAL) bind to the same site (the 
target binding cleft) of actin as profilin (Dominguez, 2004; Dominguez and Holmes, 
2011), and are therefore mutually exclusive with profilin. These proteins can not be used 
as tools for testing the accessibility. DNaseI, however, binds to a specific loop in the 
subdomain 2 (Figure 2-6), which is distant from profilin binding site. Actually profilactin 
can efficiently bind DNaseI, and this was how profilin was identified in the first place 
(Carlsson et al., 1976). So, we have chosen the D-loop of actin as another site for 
accessibility testing. 
We tested the accessibility of these sites by immobilizing the export complex to Poly-Pro 
sepharose matrix (prepared by Dirk Görlich) and DNaseI matrix (see section 6.2.5 for 
matrix preparation). As controls we also used free actin and profilin, as well as the 
profilactin and Xpo6RanGTP complexes. For Poly-Pro matrix, profilin and profilactin 
served as positive controls, whereas free actin and Xpo6RanGTP complex served as 
negative controls. On the other hand, free actin and profilactin should efficiently bind 
DNaseI matrix, where free profilin and Xpo6RanGTP were negative controls. The 
proteins were incubated with both matrices for 2 h in cold room, and after washing the 
unbound material, the bound proteins were eluted by SDS buffer. Figure 3-15 shows the 
results of the accessibility assay.  
As expected, free proline and profilactin bind to the Poly-Pro matrix, whereas free actin 
and Xpo6RanGTP show only low levels of unspecific binding. The actin export complex 
was bound to Poly-Pro matrix in near stoichiometric ratios, which indicates that the Poly-
Pro binding pocket of profilin is accessible within the export complex. Also, there is a 
certain level of contamination of the neighboring lanes with the export complex, due to the 
high concentration of protein in the loaded sample. As for the DNaseI matrix, it was seen 
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that the positive controls (actin and profilactin) were bound to the matrix as expected. 
However, the negative control (Xpo6RanGTP) was also bound to the matrix quite 
strongly, such that the results of the export complex binding could not be clearly 
interpreted. This result might be due to the insufficient quenching of the matrix after 
DNaseI coupling. 
Therefore, we decided to test the accessibility of the actin export complex with a reciprocal 
binding experiment. In this setup we immobilized actin export complex to Ni-matrix as 
described in section 3.5.1, and before the elution of the complex with the tag cleavage, we 
performed an additional 1 h incubation with DNaseI. In the control sample, we incubated 
the immobilized complex with buffer for 1 h before the elution. As seen in Figure 3-16, 
incubation with DNaseI for 1 hour efficiently dissociates most of the Xpo6RanGTP form 
profilactin. This result indicates that the binding of DNaseI to actin is not compatible with 
its binding to the export complex. 
 
Figure 3-15 Accessibility of profilactin in the export complex 
Equal and saturating amounts (1.5 µM) of Profilin (P), actin (A), profilactin complex (PA), Xpo6RanGTP complex 
(XR) and the actin export complex (comp) were incubated with either Poly-L-Pro or DNaseI matrix to test the 
accessibility of Poly-Pro binding pocket of profilin and the D-loop of actin in the export complex, respectively. Elution 
was performed with SDS buffer. Elution fractions were 10 times concentrated as the input fraction. Note that the 
complete export complex can be trapped on Poly-Pro matrix, showing the accessibility of the Poly-Pro binding pocket. In 
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Figure 3-16 DNaseI can dissociate a pre-formed actin nuclear export complex 
The export complex immobilized on Ni- matrix via the N-terminal tag of Profilin was incubated for 1h with DNaseI (in 
excess) or with buffer. The input (DNaseI), Flow through and the SUMO elution fractions were analyzed on SDS PAGE. 
Note that DNaseI efficiently displaced a large fraction of Xpo6RanGTP from profilactin. There is also minor 
dissociation in the buffer control, but much less compared to the DNaseI sample. 
 
3.8 Thermal stability analysis of Exportin 6 and its complexes 
Thermofluor assay detects the thermal denaturation of proteins via hydrophobic 
fluorescent dyes. The principles of the technique and the application areas are reviewed in 
(Boivin et al., 2013). The fluorescence signal from the dye is quenched in aqueous 
solutions, and it is enhanced when the dye binds to hydrophobic regions of proteins. For 
most globular proteins this occurs as the protein unfolds and the hydrophobic core is 
exposed. At low temperatures, measured fluorescence is low, which increases as the 
protein unfolds and it reaches its maximum during complete unfolding. As the temperature 
further increases, proteins start to aggregate, which decreases the accessibility of 
hydrophobic regions, hence the fluorescence signal drops. For NTRs, which have 
hydrophobic pockets on their surfaces, the situation is somewhat different. In our 
experiments, we used equal amounts (5µM) of free Xpo6, Xpo6RanGTP, and the export 
complex in a thermofluor assay, where the temperature was increased step-wise from 30ºC 
to 95ºC by 1ºC increments. We used 1x Sypro-Orange (Life Technologies) in the reaction 
as a fluorescent dye. Three replicates for each sample were measured. Figure 3-17 shows 
the fluorescence measurements of the Thermofluor assay. It is important to note that the 
fluorescence signal does not start from zero, as expected for globular proteins with a 
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hydrophobic core and hydrophilic surface. This indicates that the fluorescent dye interacts 
with Xpo6 also in the folded state, most probably via the hydrophobic FG binding pockets. 
The starting level fluorescence signals for the export complex are even higher than those 
for the free Xpo6 and Xpo6RanGTP. Nonetheless, a shifting trend for the fluorescence 
peaks of Xpo6, Xpo6RanGTP and the export complex can be seen. In order to determine 
the melting temperature (Tm), at which half of all molecules are denatured, the negative 
change in the fluorescence signal is calculated as a function of temperature (Figure 3-18). 
The Tm was calculated as 41ºC, 44ºC and 50ºC for Xpo6, Xpo6RanGTP and the export 
complex, respectively. These results clearly show that Xpo6 is stabilized by binding of 
RanGTP, and even further stabilized by binding of the cargo. 
 
Figure 3-17 Themofluor measurements for Xpo6, Xpo6RanGTP and the export complex 
Sypro-Orange fluorescence signal in relative fluorescence units (RFU) versus temperature. Three lines of each color 
represent the technical repeats for the respective sample; blue: Xpo6, red: Xpo6RanGTP, green: export complex. Note 
that the initial fluorescence signal is different than zero, and that this signal is far greater for the export complex than for 
Xpo6RanGTP and the free Xpo6. 
 
Figure 3-18 Melting curves for Xpo6, Xpo6RanGTP and the export complex 
The graph shows the derivative of the fluorescence signal versus temperature. Three lines of each color represent the 
technical repeats for the respective sample; blue: Xpo6, red: Xpo6RanGTP, green: export complex. The dips indicate 
the melting temperatures: 41ºC, 44ºC, 50ºC for free Xpo6, Xpo6RanGTP and the export complex, respectively. Melting 
temperature (Tm) indicates the thermostability of proteins and complexes in the particular buffer condition. Note the 
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3.9 Crystallization of Exportin 6 and its complexes 
3.9.1 Crystallization trials with Xpo6RanGTP complex 
We have used highly pure and concentrated Xpo6RanGTP complex (Figure 3-6) for 
crystallization trials. An important quality for proper crystallization substrates is the 
homogeneity of the sample. We used dynamic light scattering (DLS) to assess the quality 
of our sample. The principles of the techniques are briefly described in 6.2.10. The purified 
complex concentrated to 15 mg/mL was exceptionally pure with polydispersity values of 
5-8% (data not shown). As a rule of thumb, samples with polydispersity lower than 15% 
are considered to be good for crystallization (Geerlof et al., 2006). We used commercially 
available sparse-matrix screens and a robotic system to screen a large variety of 
crystallization conditions. We have tested two temperatures (4ºC and 20ºC) for each 
condition, which brought the crystallization conditions we screened to an estimated 3000. 
However, we couldn’t identify promising hits for crystallization of this complex 
3.9.2 Crystallization of Exportin 6 
During the crystallization trials of the Xpo6RanGTP complex, we found a condition with 
crystals, which we wanted to reproduce and improve. For the optimization screens, we 
used free Xpo6 as a control. The initial crystals were later found to be salt crystals and 
hence could not be reproduced. But in the optimization screens performed in the meantime, 
we saw that free Xpo6 showed crystalline like growth, unlike the Xpo6RanGTP complex. 
This showed us that the free Xpo6 had potential to crystallize on its own. Xpo6 was 
purified over gel filtration in a low salt buffer (10 Tris pH 7.5, 10 NaCl, 1 DTT). During 
concentration, the purified protein started to precipitate, which could be reversed by the 
increase of salt to 50 mM. It was possible to concentrate the purified protein (in 10 Tris pH 
7.5, 50 NaCl, 1 DTT) up to 25 mg/mL. The sample homogeneity was good, indicated by 
11% polydispersity in dynamic light scattering measurements (data not shown). Several 
protein concentrations (8, 17, 25 mg/mL) were tried for the initial trials. The first plates 
already showed that 8 mg/mL was too low (all drops remained clear) and 25 mg/mL was 
too high (heavy precipitation in all drops) for crystallization. 17 mg/mL protein 
concentration resulted in a dynamic precipitation behavior, which is desirable for 
crystallization. We used the robotic system for a high throughput screening of available 
commercial screens. Each screen was tested at two temperatures (4ºC-20ºC), which 
multiplied the number of conditions. Several different conditions were identified in the 
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first couple of days, where crystals or crystalline precipitations were observed. All of these 
conditions included polymer-based precipitants such as different Polyethylene glycol 
(PEG) polymers, Jeffamine or a variety of Sokalan® polymers. Jeffamine is a polyether 
diamine polymer, which is similar to and slightly more hydrophobic than PEG. Sokalan® is 
a brand name for a group of hydrophilic copolymers. Sokalan® CP5 and CP 7 are maleic 
acid/acrylic acid copolymers and Sokalan® CP 12S is a modified polyacrylic acid. Table 
3-1 summarizes the initial hits identified for Xpo6 crystallization. All hits were obtained at 
4 ºC. Selected images from the crystal drops are shown in Figure 3-19. 
 
Table 3-1 Initial crystallization conditions identified for Xpo6 
screen/condition buffer pH precipitant salt alcohol Protein concentration scoring 
Time 
scale 
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Figure 3-19 Initial crystallization hits for Xpo6 
Crystals of Xpo6 grown in various crystallization conditions, all at 4ºC. A) MIDAS-G1: 100 mM HEPES NaOH pH 7.0, 
25 % Sokalan® CP7, 100 mM KCl B) MIDAS-G11: 100 mM Bis-Tris NaOH pH 5.5, 15% Sokalan® CP12 S, 100 mM 
lithium citrate C) MIDAS-H10: 100 mM Tris pH 8.5, 25% Sokalan® CP5 D) MBclass-E8: 50 mM Tris pH 7.5, 12% PEG 
MME 2000, 500 mM NaCl E) MBclass E9: 50 mM sodium citrate pH 5.6, 10% PEG 3350, 150 mM NaCl F) MBclass-
E12: 50 mM sodium phosphate pH 6.7, 5% PEG 4000. 
 
The initial conditions we identified provided the base for the further crystallization screens. 
Refinement screens were prepared in a way that the buffer, salt, precipitant concentrations 
and the pH of the initial hits were varied in small increments to find better crystallization 
conditions. Table 3-2 summarizes the refinement screens we prepared, based on the initial 
crystallization hits for Xpo6. Some screens resulted in improved crystals, whereas some 
hits could not be reproduced. Also for the refinement conditions all crystals were obtained 
at 4ºC; no crystals appeared if the same conditions were incubated at 20ºC.  
Especially the refinements based on initial hit “MBclass E8” yielded improved and 
reproducible crystals. In the initial drop there were oval-shaped two-dimensional plates, 
whereas the refinement screens resulted in hexagonal rod-shaped crystals. The 
crystallization window of Xpo6 in this particular condition was very broad. We obtained 
crystals at PEG MME 2000 concentrations between 5-9%, at NaCl concentrations between 
50-500 mM and in a pH range of 7.0-7.8. However, the appearance and the quality of the 
crystals changed within these limits. With increasing PEG MME 2000, nucleation was 
increased; the crystals were more in number, smaller and roundish. With increasing NaCl, 
fewer and bigger crystals grew, but they were generally less sharp on their edges. The 
crystals were on average 60 µm in length, but some of them grew as large as 300 µm. The 
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crystals appeared within 24h after the setting of the drop, and continue growing for a 
couple of days. Figure 3-20 shows some examples of Xpo6 crystals obtained from the 
refinement screens based on “MBclass E8”. 
 
Table 3-2 Refinement screen conditions for Xpo6 crystallization 
Initial hit Initial condition screened precipitant salt pH Crystal range 
MIDAS/G11 
100mM Bis tris NaOH  pH 
5.5 
15% Sokalan CP 12S 




10-20% 100 mM 5.5-6.5 No crystals 
MIDAS G1 
100mM HEPES NaOH pH 
7.0 
100 mM KCl 










100mM HEPES NaOH pH 
7.0 
100 mM ammonium 
formate 




15-25% 100 mM 6.5-7.5 No crystals 
MBclass E12 
50mM Sodium phosphate 
pH 6.7 




2.5-15% - 6.0-7.0 No crystals 
MBclass E12 
50mM Sodium phosphate 
pH 6.7 









50mM Tris pH 7.5 
500 mM NaCl 










50mM Tris pH 7.5 
500 mM NaCl 











50mM Tris pH 7.5 
500 mM NaCl 










50mM Sodium citrate pH 
5.6 
150 mM NaCl 




5-15% 150 mM 5.0-6.0 No crystals 
MBclass E9 
50mM Sodium citrate pH 
5.6 
150 mM NaCl 




5-15% 0-300 mM 5.6 No crystals 
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Figure 3-20 Xpo6 crystals from the refinement of "MBclass E8" 
Crystals of Xpo6 grown in the refinement screens based on MBclass-E8 condition, all at 4ºC. A) 50 mM Tris pH 7.6, 100 
mM NaCl, 5.09% PEG MME 2000, B) 50 mM Tris pH 7.39, 100 mM NaCl, 5.73% PEG MME 2000, C) 50 mM Tris pH 
7.6, 100 mM NaCl, 5.73% PEG MME 2000, D) 50 mM Tris pH 7.0, 500 mM NaCl, 6.36% PEG MME 2000, E) 50 mM 
Tris pH 7.64, 500 mM NaCl, 5% PEG MME 2000, F) 50 mM Tris pH 7.5, 368 mM NaCl, 5% PEG MME 2000 
 
The refinement screens for “MBClass E12” hit revealed only one single condition where 
hexagonal rod shaped crystals appeared; at 50 mM sodium phosphate pH 6.56 with 4% 
PEG 4000. The crystallization window for this condition was so narrow, that even small 
changes in pH were not tolerated. The crystals appeared on day 1, and continue growing 
until day 5. We harvested this drop on day 5. At pH 6.56, PEG concentrations higher than 
4 % produced crystals that were smaller and roundish. These drops became too crowded 
with many small crystals, such that harvesting was not possible. The refinement screen 
based on “Midas G1” yielded rod-shaped crystals at 100 mM HEPES pH 6.83 and 100mM 
KCl, which got bigger with the increasing precipitant concentration (21-25% Sokalan® 
CP7). Figure 3-21 shows improved crystals from the refinement screens based on 
“MBClass E12” and “Midas G1”.  
For the X-ray diffraction analysis the crystals were frozen and transported to the 
synchrotron. Prior to freezing, crystals are brought into a cryo-condition, which causes 
amorphous freezing of the solution in liquid nitrogen. Crystalline ice is undesired as it 
interferes with the diffraction analysis of the protein crystals. Glycerol, ethylene glycol, 
and different sugars or alcohols can be used as cryoprotectants. 
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Figure 3-21 Xpo6 crystals from refinement of "Midas G1" and "MBclassE12" 
A-C: Crystals of Xpo6 grown in the refinement screens based on MIDAS G1 condition, all at 4ºC. A) 100 mM HEPES 
NaOH pH 6.83, 100 mM KCl, 22.3 % Sokalan® CP7, B) 100 mM HEPES NaOH pH 6.83, 100 mM KCl, 23.2 % 
Sokalan® CP7, C) 100 mM HEPES NaOH pH 6.83, 100 mM KCl, 24.1 % Sokalan® CP7. D-F: Crystals of Xpo6 grown 
in the refinement screens based on MBclass E12 condition, all at 4ºC D) 50 mM sodium phosphate pH 6.56, 4% PEG 
4000, E) 50 mM sodium phosphate pH 6.56, 4,23% PEG 4000, F) 50 mM sodium phosphate pH 6.56, 4% PEG 4000 
 
Cryo-conditions were prepared for each condition separately. Buffer and salt 
concentrations and pH were kept the same as the crystallization condition, the precipitant 
concentration was increased to 25% and 15% glycerol was added. The crystals were 
slowly acclimatized to the cryo-condition in order to minimize damage. We could not 
identify an appropriate cryo-solution for Sokalan® CP7 conditions, as the solution 
crystallized in liquid nitrogen, despite the addition of glycerol up to 25%. The crystals 
from the refinement screen based on Sokalan® CP7 could therefore not be analyzed for 
their diffraction. We analyzed the diffractions of other crystals at Swiss Light Source PX II 
beam line. The best resolution was obtained from Xpo6 crystals grown in refinement 
screens “MBclass E8”, and the crystals diffracted to 7.4 Å. We could determine the space 
group (152, P3121) and unit cell dimensions (203, 203, 258 Å / 90º, 90º, 120º). The 
crystals grown in different conditions were found to belong to the same space group with 
similar unit cell dimensions (Figure 3-22). The crystals grown in PEG MME 2000 
conditions (MBclass E8 refinements) were the most reproducible crystals, with the best 
diffractions obtained (7.4 Å). However, we could not detect a trend between the diffraction 
quality and the salt, precipitant concentrations and pH of the conditions. 
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Figure 3-22 Xpo6 crystals and their diffractions 
Representative images of Xpo6 crystals and their diffraction patterns. The diffraction data were collected at the Swiss 
Light source, PXII beamline, at 1Å wavelength. So far the best diffraction were obtained from the crystals shown in A. 
Space group of the crystals in A and C were found to be the same, although grown in different conditions. No diffraction 
could be detected for the crystals shown in B. 
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3.9.2.1 Limited proteolysis and secondary structure prediction of Xpo6 
Flexible regions in proteins or protein complexes may interfere with proper crystal 
packing, and limit diffraction resolution of crystals. Such flexible regions can be identified 
by limited proteolysis. Proteases first target the most accessible regions such as loops or 
flexible ends rather than the folded core of the protein. When proteases are used in very 
low amounts, the proteolysis pattern can be used to identify the flexible regions of a 
protein. These regions may then be removed in order to obtain crystallizable products or to 
improve diffraction of the crystals. For Xpo6, we used three different proteases in limited 
proteolysis assay. Trypsin cleaves C-terminally at basic residues such as lysine and 
arginine. Chymotrypsin cleaves C-terminally at aromatic residues such as tryptophan, 
tyrosine and phenylalanine but also of other hydrophobic residues such as methionine and 
isoleucine. Glu-C cleaves C-terminally at the acidic glutamate residues. A serial dilution of 
the proteases in low concentrations was used to obtain a digestion pattern (for 
concentrations and the protocol see 6.2.11). The digestion pattern is shown in Figure 3-23. 
The indicated bands were analyzed by mass spectrometry to identify the protease cleavage 
sites. The identified Trypsin and chymotrypsin digestion sites were towards the C-terminus 
of the protein whereas Glu-C digested at one site towards the N-terminus of the protein. 
 
Figure 3-23 Limited proteolysis of Xpo6 
3 µg of Xpo6 was incubated with varying concentrations of different proteases for 1h at 22 ºC. The digestion pattern was 
analyzed by SDS-PAGE and the fragments indicated with red stars were analyzed by mass spectrometry. The fraction 
numbers indicate the dilution factor of the protease used for the reaction from the working stock: 0.1 mg/mL. UC: uncut 
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In parallel, we ran secondary structure predictions with Xpo6 to compare with the limited 
proteolysis results. We used online secondary structure prediction tools such as Psipred 
and Consensus (see 6.1.7). Figure 3-24 shows a secondary structure prediction from 
Psipred online tool. The identified protease cleavage sites are also indicated in the figure. 
Two long stretches without helix predictions was the first striking outcome of the structure 
predictions. The two regions were identified as 1 (aa 200-240) and 2 (aa 280-300) in the 
Figure 3-24. The helices predicted within these regions were shorter than the typical 
HEAT repeat helices, and not every prediction algorithm could predict helices in these 
regions. A very encouraging finding was that the identified Glu-C cut-site was within the 
first loop region. Trypsin and chymotrypsin cut-sites corresponded to small inter- or 
intrahelix loops towards the C-terminus. We also found a very acidic stretch corresponding 
to a helix-free region. By analogy with other nuclear export receptors, we infer that this 
region (aa 470-480) might correspond to the “acidic loop” that serves as an important 
binding site for RanGTP. We created several truncations of these three regions, in order to 
obtain a less-flexible crystallization substrate. We first compared the gel filtration profiles 
of the truncations with the full length Xpo6. The truncations of the second loop and the 
acidic loop eluted at the same volume as the full length Xpo6, whereas all truncations of 
the first loop eluted 0.2 mL later in a SD200 10/30 column (Figure 3-25). This indicates 
that the removal of the first loop made Xpo6 smaller in overall size. This can be possible if 
the region is located on the outer surface of Xpo6. Next, we analyzed the truncated Xpo6 
versions for their ability to form complexes with RanGTP and profilactin. The binding 
assay was performed as described in 3.5.1. Table 3-3 summarizes the Xpo6 truncation 
constructs and their properties such as gel filtration behavior, aggregation and the ability to 
form an export complex. 
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Figure 3-25 Gel filtration profiles of Xpo6 truncations 
Gel filtration profiles of the full length and truncated human Xpo6 versions in 50 mM Tris pH 7.5, 500 mM NaCl, 5 mM 
DTT. The chromatograms are overlaid to scale. A) Gel filtration chromatograms of the truncations of the first loop versus 
full length Xpo6. Note that there is a shift of the peak by 0.2 mL, constant for all truncations. B) Gel filtration 
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chromatograms of the truncations of the second and acidic loops versus full length Xpo6. Note that the Xpo6 versions 
elute at the exact same volume. 
 
 
Figure 3-26 Actin export complex formation with Xpo6 truncations 
Full length Xpo6 and the truncated versions are compared for their ability to form an export complex. The experimental 
setup was identical to Figure 3-10. The buffer conditions for binding were kept identical: 10 mM Tris pH 7.5, 20 mM 
NaAc, 1mM DTT, whereas each reaction had a different Xpo6 variant. Complex was immobilized through profilin, and 
the amount of Xpo6RanGTP bound to profilactin was used to judge the complex stability. 
 
Table 3-3 Xpo6 loop truncations and their properties 
(% Aggregation was calculated by the area of the void volume divided by the sum of the void and peak areas) 
Name Deletion 
region 









- - 12.44 5% yes 
Tr1 Loop 1 201TAATPPPSPTSGESGDLLSNLLQSPSSA
KLLNQPIPILDV240 
12.62 46% yes 
Tr2 Loop 1 201TAATPPPSPTSGESGDLLSNLLQSPSSA
KLLNQPIPIL238 
12.64 29% yes 
Tr3 Loop 1 202AATPPPSPTSGESGDLLSNLLQSPSSAK
LLNQPIPIL238 
12.63 26% yes 
Tr4 Loop 1 203ATPPPSPTSGESGDLLSNLLQSPSSAKL
LNQPIPIL238 
12.63 19% yes 
Tr5 Loop 1 205PPPSPTSGESGDLLSNLLQSPSSAKLLN
QPIPILDV240 
12.64 36% yes 
Tr6 Loop 2 281GCDIRARKMASVNGSSQNCVSGQER305 12.45 38% yes 
AL-1 Acidic 
loop 
469QLEELDDETLDDDQQ483 12.44 56% no 
AL-3 Acidic 
loop 
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As seen in Figure 3-26, Xpo6 versions with truncations in the first loop (Tr1-5) and 
truncation in the second loop (Tr6) retain their ability to form an export complex. This 
outcome further implied that the removal of these predicted loops did not disturb the 
overall folding and function of Xpo6. On the other hand, truncation of the acidic loop 
(AL1, AL3) severely hindered complex formation, indicating that this region might be 
involved in direct interactions with RanGTP and/or the cargo. We have chosen 2 
truncation constructs of the first loop (Tr3 and Tr4) and one truncation construct of the 
second loop (Tr6) and used them in crystallization trials. With the truncated versions, we 
have screened the refined conditions for Xpo6 crystallization, as well as a wide range of 
commercial sparse-matrix screens, but we couldn’t identify suitable conditions for 
crystallization so far. 
3.9.2.2 Sequence conservation of Xpo6 in evolutionary distant species 
In parallel to the secondary structure predictions, we also analyzed the sequence 
conservation of Xpo6 in other species. We used the position-specific-iterated BLAST 
(PSI-BLAST) tool of NCBI, which was more powerful than normal BLAST tools in 
identifying the Xpo6 sequences with low overall conservation. We specifically looked at 
the conservation of the predicted loop regions. Loops that are not directly involved in 
cargo recognition are more likely to be divergent. Indeed, we found that the conservation 
in these regions were lower than the regions that corresponded to predicted helices. 
Especially in evolutionary distant species like the tunicate Ciona intestinalis and the slime 
mold Dictyostelium species, these loop regions were significantly shorter. Also in the 
Xpo6 sequences from Xenopus laevis and Xenopus tropicalis, the loop regions are 
strikingly less conserved compared to the rest of the protein. Also second loop region has 
an insertion in all Xenopus isoforms we analyzed. This was a further indication that the 
deletion regions corresponded to loops that are not essential for Xpo6 function. Xpo6 from 
birds and mammals showed quite high conservation throughout the entire sequence. Figure 
3-27 shows the Xpo6 alignments from selected species in comparison to human Xpo6. 
Our loop truncations on Xpo6 might be very crude and have negative effect on the overall 
fold of the protein, and may hinder crystallization, rather than improving. Using an Xpo6 
version that is trimmed over millions of years by evolution might be a more elegant 
approach to solve the problem with flexibility. We have chosen Xpo6 of two species, 
Dictyostelium purpureum and Dictyostelium fasciculatum for later crystallization studies.  
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Figure 3-27 Sequence conservation of Xpo6 in different species 
A) Alignment of Xpo6 sequences from human, X. laevis and X. tropicalis. The predicted loop regions were shown in red 
boxes. Note the low conservation in these regions compared to the rest of the sequences. Also there is an insertion in the 
loop 2 regions in frog sequences. B) Alignment of Xpo6 sequences from human chicken and D. purpureum and D. 
fasciculatum. The predicted loop regions were shown in red boxes. Note the missing sequences in slime mold Xpo6 
versions, corresponding to the predicted loop regions. Xpo6 from chicken is highly similar to human Xpo6 throughout 
the entire sequence. 
 
Using shorter versions of a protein is a frequently used approach in crystallization. Another 
approach is using proteins from thermophilic organisms. Proteins from thermophiles are 
evolved to withstand high temperatures, and are therefore more rigid in ambient or low 
temperatures used for crystallization, compared to their mesophilic counterparts. Since 
NTRs are only present in eukaryotes, thermophilic fungus Chaetomium thermophilum is 
the favorite choice for NTR crystallization studies (Monecke et al., 2013). However, Xpo6 
being absent in fungi, this species is not a likely solution for us. We therefore decided to 
use Xpo6 from species with slightly higher body temperatures than humans. Birds with an 
average 41ºC body temperature were the first choice. We decided to use Xpo6 from 
chicken, and would also like to test whether chicken Xpo6 works better with chicken 
skeletal actin. We expressed and purified Xpo6 from chicken (ggXpo6), D. purpureum 
(dpXpo6) and D. fasciculatum (dfXpo6) and tested them in a complex formation assay 
with RanGTP and profilactin in comparison to human Xpo6. The binding assay was 
performed as described in 3.5.1. We also used Xpo6 from Xenopus laevis as another 
positive control. ggXpo6 was indistinguishable from human and Xenopus Xpo6 in terms of 
A) Sequence alignment of human and Xenopus Xpo6 
B) Sequence alignment of human, chicken and Dictyostelium Xpo6 
loop regions 1 and 2
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complex formation. However, neither dpXpo6 nor dfXpo6 was bound to profilactin in this 
setup  (Figure 3-28-A). Before giving up hopes on our new species, we wanted to test them 
on a phenyl sepharose matrix that is now known to increase the stability of the actin export 
complex.  
 
Figure 3-28 Export complex formation with new Xpo6 species 
Xpo6 from human, frog, chicken and slime mold were compared for their ability to form an export complex. The buffer 
for each binding reaction was the same: 10 mM Tris pH 7.5, 20 mM NaAc, 1 mM DTT  A) Complex was immobilized 
through profilin, and the amount of Xpo6RanGTP bound to profilactin was used to judge the complex stability. 
Experimental setup was identical to Figure 3-26. Note that human frog and chicken were similar, whereas the Xpo6 from 
slime molds did not form a complex. B) Complex formation was tested on phenyl sepharose matrix. Experimental setup 
was identical to Figure 3-4. The Note that human and chicken Xpo6 are similar, whereas the Xpo6 from slime molds 
bind weaker to RanGTP and profilactin. However, the binding is specific and significantly higher than background as 
shown by the control: without any Xpo6. 
 
Indeed both dpXpo6 and dfXpo6 bound RanGTP and profilactin. The binding was weaker 
compared to human and chicken Xpo6, but it was clearly stronger than background control 
(Figure 3-28-B). The difference between a weak binding and no binding is very significant. 
We can say that Xpo6 from these two evolutionary distant species still retain the ability to 
bind Ran, actin and profilin from human. The binding may be enhanced if the binding 
partners are chosen form the same species. We will use these new Xpo6 constructs for 
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3.9.3 Crystallization of the actin nuclear export complex 
We used the purified actin export complex (Figure 3-13) for crystallization trials. The 
sample was concentrated to 15 mg/mL, with good polydispersity values (12%). As a 
control we have used Xpo6RanGTP complex at 15 mg/mL concentration, purified in the 
same buffer. Using the robotic system we have screened a broad range of conditions using 
commercially available sparse matrix screens (6.1.6). For each screen we have prepared 
plates for two different temperatures (4ºC and 20ºC). We identified several conditions, 
where promising crystalline growth was observed. Figure 3-29 shows images of some of 
the initial hits. Interestingly, for the actin export complex all hits were from plates at 20ºC. 
in their counterparts at 4ºC, no crystals have been observed. For the conditions termed as 
initial hits, Xpo6RanGTP controls did not show any crystalline growth.  
 
Figure 3-29 Initial hits for actin nuclear export complex crystallization 
The crystallization conditions and temperature are indicated. A) needle crystals appear at day one and continue to grow 
until day 30. The crystals are indicated with the red boxes. B) numerous small needles appear on day 3, but do not grow 
further. C) Dark precipitates appear on day one and grow outwards as needles.  
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It was an interesting observation that all the initial hits were conditions that did not contain 
any salt. Considering the ionic sensitivity of the actin export complex, this was a positive 
indication. Two of the initial hits were especially promising. In one condition (10% PEG 
6000, 10 mM MgCl2) a small needle crystal appeared in day 1, and continued growing as a 
bunch of needles until day 30. In another very minimalistic condition (15% PEG 1500), 
numerous small needles appeared at day 3, but they did not grow further. Another possible 
hit is an alcohol-based condition, which also contains a high concentration of heavy metal 
salt (40% MPD, 200mM CdCl2). In this condition, dark precipitates appeared on day 1, 
and continued growing radially in a way that resembles crystalline growth. It is possible, 
however, that those are crystals of the heavy metal salt. 
We prepared refinement screens for conditions based on PEG 6000 and PEG 1500. For the 
first hit, we kept the 10 mM MgCl2 fixed, whereas we varied PEG 6000 concentration 
from 0-25% over 96 wells of the screening plate. For the other refinement screen we 
scanned PEG 1500 concentrations of 0-20%. Unfortunately, we could not identify a better 
crystallization condition, nor we could reproduce the initial observations.  
Nucleation is a rare event, and it is possible that it can not be reproduced. But nucleation 
step could be by-passed with a technique called seeding. In seeding method, sub-optimal 
crystals are crushed to form microcrystals, which act as nuclei for the next round of 
crystallization. We wanted to use the needles obtained in the initial screen (10% PEG 
6000, 10 mM MgCl2) as seeds for our refinements. The needle crystals were taken out 
from the drop and a seed stock solution was prepared (see 6.2.13.4). While preparing new 
reservoir solution for the manual seeding experiments, we realized that the pH of the 
manually prepared PEG 6000 solution was very acidic (pH 4.3). Although the commercial 
screen did not have any buffer in the condition, they might have pH adjusted the PEG 6000 
solution, which was not explicitly described in the manuals. Considering that the pH might 
have been the reason why we did not see any crystals in our refinements, we added 100 
mM Tris pH 7.5 to the solution. The pH was then manually confirmed. Using the seed 
stock dilutions and the newly prepared reservoir solution (10% PEG 6000, 10 mM MgCl2, 
100 mM Tris pH 7.5) we prepared our seeding drops. Serial dilutions of the seed stock 
with reservoir were mixed with protein (15 mg/mL) in 1:1, 1:2 ratios and sealed in small 
chambers with reservoir at room temperature. Bunches of needles appeared in almost all 
dilutions of the seed stock within 1-2 days. On the third day, needles appeared also in the 
control drops without seed stock, but only reservoir. A characteristic bowtie shape was 
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observed: needles from one nucleus usually grew towards both directions radially. Figure 
3-30 shows the crystals obtained in manual drops. 
 
Figure 3-30 Reproduction of the actin nuclear export complex crystals 
The needles from the initial hit (10% PEG 6000, 10 mM MgCl2) were used to prepare seeds, which were used in the 
manual crystallization drops with the following crystallization solution: 100 mM Tris pH 7.5, 10% PEG 6000, 10 mM 
MgCl2. In drops with various seed concentrations (A, C, D), as well as in drops without seeds (B), needle shaped crystals 
could be reproduced in several days at room temperature. 
 
The crystals were reproducible with and without seeding, and there were no visible 
improvements in the crystal shape due to seeding. We therefore wanted to know what the 
crystals were made of: was it the tetrameric export complex or any of the sub-complexes? 
In order to investigate the content of the crystals, we removed them from the crystallization 
drop with a nylon loop, and washed them in a fresh drop of reservoir in order to prevent 
carry over of soluble protein from the solution. Finally the crystals were placed in 5 µL of 
fresh reservoir in a tube. Two drops were harvested as described and several crystals from 
each drop were combined and analyzed by SDS PAGE. As a control, 1µL of protein 
sample was loaded to the gel. Figure 3-31 shows the SDS PAGE analysis of the crystals 
from two separate drops. As can be seen, all four proteins were present in both crystals. 
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We have managed to crystallize the full actin nuclear export complex from human, and 
that in a very minimalistic condition: 10% PEG 6000, 10 mM MgCl2, 100 mM Tris pH 
7.5. For sure the crystals are still not optimal for diffraction analysis and require further 
optimizations. But it was very important to show that the full-length human actin nuclear 
export complex can be crystallized, despite its ionic sensitivity, the low affinity between its 
sub-complexes and even the possible inhomogeneity in the crystallization sample. In the 
end the crystallization process itself has been the ultimate purification in a mixed 
population between the full complex and sub-complexes. 
 
Figure 3-31 SDS PAGE analysis of the actin nuclear export complex crystals 
The needle crystals from the manual drops were fished, washed in fresh reservoir and resuspended in reservoir solution 
with SDS buffer. The content of the crystals were analyzed with SDS-PAGE, and a microliter of the protein sample was 
loaded as a reference. Crystals from two different drops are shown here to contain all four proteins of the export complex. 
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4 Discussion 
4.1 Actin isoforms and the complex stability 
We have shown that the muscle α actin was not a very good substrate for export complex 
formation in vitro. This was mainly due to the lower affinity of α actin towards profilin. 
The lower affinity of α actin towards profilin than its cytoplasmic counterparts (β/γ) has 
been reported previously (Larsson and Lindberg, 1988; Ohshima et al., 1989; Vinson et 
al., 1998; Kinosian et al., 2000). Profilin is a multi-functional protein in actin cytoskeleton 
dynamics. It has a major role in the ATP loading of actin monomers, and their addition to 
the barbed end of the actin filaments (Sohn and Goldschmidt-Clermont, 1994). Since the 
cytoplasmic actin filaments are more dynamic and have a higher turnover rate than the 
sarcoplasmic actin bundles, it makes perfect sense that the cytoplasmic (β/γ) actin isoforms 
show higher affinity towards profilin, which assists the re-polymerization of the recycled 
monomers. Also, α actin was shown to polymerize more readily than β actin, especially at 
low temperatures (Gordon et al., 1977). Actin in its filamentous form is not accessible for 
profilin or Xpo6. It was actually shown that Xpo6 efficiently exports α actin from the 
Xenopus oocyte nuclei (Bohnsack et al., 2006). This is, however, not exactly controversial 
with our findings, considering that many other cellular factors can stabilize the export 
complex in vivo.  
For all the obvious benefits, we decided to use an actin isoform with higher affinity for 
profilin, and hence for the complex. Using HeLa cytoplasmic extract as a source for actin 
was the immediate choice. Department of cellular biochemistry at the MPI for biophysical 
chemistry has an established protocol for preparing nuclear and cytoplasmic HeLa extracts 
and they have generously supplied us with large amounts of cellular extract. Cytoplasmic 
actin is a mixture of two isoforms; β actin and γ actin are found in varying ratios in 
different tissues (Herman, 1993; Perrin and Ervasti, 2010). The isoforms can be separated 
via hydroxyapatite chromatography (Segura and Lindberg, 1984), however the use of this 
resin is cumbersome. At the beginning we were concerned whether the mixed isoforms 
would be a good substrate for crystallization. However, β and γ actins are almost identical, 
except for four very conserved amino acid changes at the extreme N-terminus of the 
protein. There are also previous studies reporting successful crystallization of β and γ actin 
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isoforms (Carlsson et al., 1976). For this reason we decided to use the cytoplasmic actin 
without further separation of the isoforms. 
4.2 Stable Xpo6RanGTP interaction in the absence of the cargo 
Xpo6 binds RanGTP strongly, as shown in section 3.3, even in the absence of its cargo. 
This indicates a cargo recognition mechanism that is different than CRM1 and CAS, which 
have both very low affinity towards RanGTP in the absence of their respective cargos 
(Fornerod et al., 1997; Kutay et al., 1997). A strong affinity towards RanGTP is a feature 
that is characteristic to importins. RanGTP, due to this high affinity, is able to disassemble 
import complexes when they arrive in the nucleus. This brings up the question whether 
Xpo6 might have an import function parallel to the actin export. There are already known 
bidirectional NTRs, such as the importin 13 (Mingot et al., 2001) and exportin 4 
(Lipowsky et al., 2000; Gontan et al., 2009). Also Msn5 in yeast is known to export one 
set of cargos including transcription factors and cyclin inhibitors, while importing RPA, an 
important protein in DNA replication and repair (Yoshida and Blobel, 2001). It is possible 
that Xpo6 is indeed specific for only one single task, but it might as well have other 
functions in import or export. Relatively high background in the pull-down experiments 
(Stuven et al., 2003) might have been the reason, why no other cargo for Xpo6 was 
identified so far. We can now overcome this problem by using the new affinity tag & 
matrix systems that are developed in our lab, which show almost no unspecific binding in 
the cellular extracts. Also, if one is looking for potential import cargos, using a nuclear 
extract for the pull-down experiments will increase the likelihood of identification. For 
identifying potential export cargos beside actin, one would rather use a cytoplasmic extract 
that is actin-depleted, in order to be able to identify less abundant potential cargos. 
4.3 Crystallization of human Xpo6 
While setting up the crystallization screens for Xpo6, we saw that the concentrated Xpo6 
(25 mg/mL) showed some precipitation after standing on ice overnight. The sample was 
ultra centrifuged to remove precipitates and the pellet was observed under a light 
microscope. To our great surprise, we saw that the precipitates were actually small needle 
crystals, some of which we could also detect in the newly pipetted crystallization plates. 
This was a good indication that free Xpo6 had a potential to crystallize. In accordance with 
this, we identified several different conditions, where Xpo6 showed some crystalline 
growth. All identified conditions had polymers as precipitants such as polyethylene glycol 
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(PEG), Jeffamine® and a variety of Sokalan® polymers. PEG as precipitant seemed to be 
preferred at rather low concentrations for crystallization. The identified conditions were 
reproducible, even after 2 freeze/thaw cycles of the sample. Some protein samples may not 
tolerate a freeze/thaw cycle, and thus can only be crystallized if they are freshly prepared. 
That Xpo6 may be crystallized after freeze/thaw is a great advantage, enabling us to 
prepare protein in large scale, freeze in aliquots and use for crystallization whenever 
necessary. So far, the diffraction of the Xpo6 crystals was limited to 7.4 Å. The mosaicity 
was low, indicating proper packing of crystals; and the completeness of the data was 100% 
up to the resolution limit. We did not observe a trend in the resolution of crystals relative 
to the pH, salt and precipitant concentration of the crystallization conditions. The space 
groups for crystals from two different conditions (PEG MME 2000 and Sokalan CP 12S) 
were found to be the same (trigonal P3121). Unit cell dimensions were quite large: 203, 
203, 258 Å. Considering the average dimensions of NTRs (about 5x10 nm) (Monecke et 
al., 2009; Bono et al., 2010), many Xpo6 molecules are expected to be found within the 
unit cell. 
In order to improve resolution of the Xpo6 crystals, we tried to identify and remove the 
possible flexible loops from the protein. Combining the limited proteolysis experiments, 
secondary structure predictions and the sequence conservation analysis two possible loop 
regions were identified, which we truncated from the full-length construct. Removal of 
loops would make the protein more compact and hence might enhance the solubility during 
recombinant production. We did not observe an increase in the solubility for the constructs. 
Also, a greater portion of the truncated Xpo6 versions eluted from the gel filtration as high 
molecular weight assemblies. These soluble aggregates might indicate a sub-optimal 
folding of the truncated Xpo6. While removing internal loops, one has to leave enough 
amino acids to properly bridge the adjacent folded domains. We created several truncation 
versions, with up to 4 amino acids as linkers between the two neighboring helices. All the 
loop truncations did bind to RanGTP and profilactin in the binding assays, indicating that 
the removal of the loops did not interfere with the function. However, we could not 
produce any crystals with the three of the Xpo6 truncations we tried in crystallization 
screens. This could simply be a result of the crude screening for the optimal linker length. 
A tension created in the molecule because of a too-short linker may result in positional 
shifts in the potential crystal contact points of the molecule. By screening the linker length 
in more precision, one could reach a perfectly trimmed Xpo6 for crystallization. These 
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loops might not have direct functions in cargo binding, but they might otherwise be related 
to the Xpo6 function. They may for example, interact with the FG nucleoporins and be 
involved in the docking or in the NPC passage of Xpo6. These possibilities can be tested 
by hydrogel permeation assays (Frey and Gorlich, 2007), or by export assays with 
permeabilized HeLa cells. 
Along with the manual truncations of Xpo6 we have chosen Xpo6 from other species as 
alternative crystallization substrates. Xpo6 from chicken was selected because of the 
slightly higher body temperatures of these animals. Proteins that are adapted to higher 
temperatures are preferred for crystallization in order to reduce flexibility. Proteins would 
be more rigid with the increasing difference between the optimal temperature and the 
crystallization temperature. Xpo6 species from two slime molds were chosen, because of 
their overall smaller size and their missing sequences at the two identified loop regions. 
Another approach that we will try for improving crystallization is the use of nanbodies. 
Nanobodies are small (15 kDa) and stable single-domain fragments of the original heavy 
chain–only antibodies that naturally occur in camelids (Muyldermans, 2013; De Meyer et 
al., 2014). They retain the full antigen-binding capacity of the antibodies, and have several 
other features that make them useful aids for improving crystallization. They bind the 
target with nanomolar affinity and often recognize epitopes that are less immunogenic or 
accessible for conventional antibodies. Nanobodies generally bind conformational epitopes 
and might stabilize flexible regions of proteins in a given position. They also might 
stabilize the protein-protein interfaces in multi-protein complexes. There are already 
numerous examples of nanobodies successfully being used as crystallization chaperones 
(Loris et al., 2003; Korotkov et al., 2009; Lam et al., 2009). Our lab recently established a 
workflow for the development and purification of nanobodies from alpacas we have at the 
institute. We have used free Xpo6, Xpo6RanGTP, and actin nuclear export complex for 
immunization of an alpaca over the course of one year. We then isolated RNA from the 
animal for the development of libraries. Next step will be the creation of a library, 
selection of high affinity binders using phage display system and characterization of the 
nanobodies. We expect to identify several high affinity binders for Xpo6 and also other 
complexes that may significantly improve crystallization. 
   75 
4.4 Xpo6 in evolutionary distant species 
Using a shorter version of Xpo6 might be of great advantage for crystallization, but one 
also has to consider the conservation of function. The Xpo6 from D. purpureum and D. 
fasciculatum are only 30% identical to the human protein in sequence. In binding assays 
described in section 3.9.2.2, we could show that Xpo6 from these evolutionary distant 
organisms still retain their capability to bind profilactin in a RanGTP dependent manner. 
However, whether these Xpo6 variants still function in actin export in the host organisms 
remains to be answered. If one looks at the evolutionary conservation of Xpo6, one can see 
that it is not as nearly conserved as CRM1 or Impβ. One can find Xpo6 in all vertebrates, 
and in some other chordates. Xpo6 sequences are also found in insects and arachnids, but 
not in nematodes or other lower animals. Xpo6 is also absent in fungi and plants. However, 
one finds Xpo6 in slime molds, which are evolutionarily more distant to vertebrates than 
fungi. The question, when Xpo6 was invented during evolution, is a puzzling one. Whether 
it was invented independently for the distant branches of the phylogenetic tree, or whether 
the fungi and the lower animals have lost it can not be determined easily. In order to be 
able to differentiate between these scenarios, one needs more complete sequence 
information. There are only two exceptional examples of Xpo6 in nematodes and fungi: 
Trichinella spiralis, a parasitic worm for pigs, rodents and humans and Batrachochytrium 
dendrobatidis, a parasitic fungus for frogs and fish. It is likely that these species acquired 
Xpo6 via horizontal gene transfer from their hosts over the course of time. Therefore, it is 
tempting to think Xpo6 in slime molds might also be a result of horizontal gene transfer. 
Slime molds are soil organisms that contribute to the decomposition of organic material 
and feed on bacteria yeasts and other fungi. Decaying animals in the soil might be a likely 
route for the horizontal gene transfer. If slime molds acquired Xpo6 through horizontal 
gene transfer, it would be interesting to see whether Xpo6 still retains its function to export 
actin from the nucleus.  
4.5 Ionic sensitivity of the actin nuclear export complex 
Our results showed that the actin export complex is made of two sub-complexes: 
profilactin and Xpo6RanGTP. These sub-complexes are stable in moderate up to high salt 
concentrations, respectively. However, the interaction between them is very sensitive to 
ionic strength of the buffer. We showed that the association between Xpo6RanGTP and 
profilactin can completely be abolished by increasing the NaCl concentration to 100 mM. 
Such high sensitivity to ionic strength can be explained if the interface between the sub-
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complexes is stabilized by ionic interactions. Ionic species in the buffer can interact with 
the charged residues and disrupt the salt bridges between the sub-complexes. An 
interesting finding along these lines was that the actin export complex tolerated NaAc 
better than NaCl. Cl- ion might be more effective in disrupting the ionic interactions due to 
its small size, compared to the much larger acetate ion. We also observed a much lower 
stability of the actin export complex in potassium phosphate buffers. Interestingly, in this 
buffer, the complex stability also showed a greater pH dependency. At lower pH, complex 
was less stable, whereas the stability gradually increased with increasing pH. pH variations 
can also change the ionization states of the amino acid side chains, which in turn will have 
an effect on the ionic interactions. When our observations are taken into account, it is 
highly likely that the interface between Xpo6 and actin is maintained by salt bridges. 
In addition to the ionic sensitivity, the overall affinity profilactin for the complex seems to 
be low, implied by the tailing of the complex peak during MALS analysis gel filtration. 
Also the calculated Mw of 177 kDa for the peak is lower than the expected Mw for the 
full-length complex, 205 kDa. The discrepancy (28 kDa) corresponds to the half of the Mw 
of profilactin (57 kDa) and can be explained if the peak population consists of the full 
export complex and Xpo6RanGTP. Despite the low affinity, we can say that the on-rate 
for the complex formation is far greater than the off-rate. We can conclude this from the 
observation that longer incubation times of the sub-complexes increased the complex yield 
during our experiments. 
4.6 Phenyl sepharose stabilizes the actin nuclear export complex 
Ionic strength at physiological conditions is already above the limit of what the actin 
nuclear export complex tolerates in vitro (100 mM NaCl), yet the complex exists and is 
functional in vivo. There must be other factors stabilizing the export complex in the cell. 
Also the molecular crowding within the cell might stabilize the complex. Most 
importantly, the central channel of the nuclear pore complex interacts with NTRs via the 
FG repeats of nucleoporins (Ribbeck and Gorlich, 2002). Binding to FG repeats might 
stabilize Xpo6 in its cargo bound conformation. It was therefore a very interesting 
observation that the actin export complex was not nearly as sensitive to ionic strength 
when it was assembled on phenyl sepharose matrix. Phenyl sepharose matrix is known to 
bind NTRs with high affinity (Ribbeck and Gorlich, 2002). It is possible that phenyl 
sepharose mimics the NPC environment by occupying multiple FG binding pockets of 
Xpo6 simultaneously. We tried to reproduce this effect by the addition of phenyl- or 
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benzyl- group containing compounds (phenylmalonate, benzylmalonate, sodium benzoate, 
phenylacetate, etc) in the complex formation reactions. The addition of such compounds 
did not improve the stability. It is likely that a stabilizing effect is a result of the occupation 
of multiple binding pockets in a close proximity, which can not be achieved by single 
phenyl groups.  
Another observation that supports this idea came from the thermofluor assays. As shown in 
section 3.8, we obtained fluorescence signals before the start of the melting, indicating that 
the fluorophore interacts with Xpo6 even when it is not denatured. However, the more 
interesting result of this experiment was that the fluorescence signal at 30ºC for the export 
complex was significantly higher compared to Xpo6 and RanGTP. This could indicate that 
upon cargo binding, Xpo6 undergoes conformational changes that further expose the 
hydrophobic FG-binding pockets. This observation is in accordance with the stabilizing 
effects of the phenyl sepharose on the export complex. 
4.7 Topological analysis and crystallization of the actin nuclear 
export complex 
We performed several binding experiments to test the accessibility of profilactin within the 
export complex. With this we wanted to understand which part of the profilactin molecule 
might be in direct contact with Xpo6 and possibly RanGTP. The poly-L-Proline binding 
pocket of profilin was the first region to look at. We could indeed immobilize the full 
export complex to a Poly-Pro sepharose matrix via the binding pocket of profilin. For this, 
there should be no steric hindrances and profilin should be freely accessible. Poly-L-Pro 
binding pocket is localized opposite to the actin-binding interface, and it is therefore likely 
that profilin faces rather outwards in the complex, whereas actin is directly contacted by 
Xpo6. Mena, VASP and mDia are formins known to interact with profilin via their proline 
rich sequences. They were also identified in the initial Ran dependent Xpo6 pull-downs 
(Stuven et al., 2003). In the light of this finding, one can also speculate that these proteins 
bind to the actin export complex via the accessible poly-L-pro binding pocket of profilin 
during the pull-down experiment.  
DNaseI binding loop of actin is localized in the subdomain 2, on the opposite side of the 
profilin binding interface of actin (Figure 4-1). Our results showed that DNaseI efficiently 
dissociates Xpo6RanGTP and bind profilactin, when incubated with a pre-formed export 
complex. However, it is not straightforward to interpret the result of the experiment. There 
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are two possibilities, which may lead to the same outcome. One possibility is that the D-
loop of actin is accessible in the context of the export complex, yet the binding of DNaseI 
to D-loop is sterically not compatible with Xpo6 binding. In this scenario, DNaseI can 
efficiently displace Xpo6, owing to the fact that its affinity to actin higher than that of 
Xpo6. Another possibility is that the D-loop contacts Xpo6, and is not accessible for 
DNaseI. In this case, DNaseI can only bind actin, when Xpo6RanGTP dissociates from 
actin as a result of the off-rate. DNaseI binding would make actin inaccessible for the re-
binding of Xpo6, hence DNaseI will slowly replace Xpo6. Dissociation of Xpo6RanGTP 
from profilactin was also seen in the negative control that was incubated with buffer for 
one hour. With the information derived from this experiment, we can not discriminate 
between the two scenarios, but we can say that Xpo6 possibly contacts actin near its 
pointed end, leaving profilin mostly accessible for other binding partners. 
 
Figure 4-1 Mapping of the binding sites on the actin monomer 
Profilin and DNaseI are represented on a single actin monomer. Also, the Pro-rich peptide of VASP is shown in the Poly-
Pro-binding pocket of profilin. In our experiments we found that this pocket was available in the context of the complex, 
but the binding of DNaseI to profilactin was incompatible with Xpo6 binding. Image is prepared using PyMol using data 
for actin and DNaseI from the structure with PDB-ID: 2A42 (Chereau et al., 2005), for profilin and the bound Pro-rich 
VASP peptide from the structure with PDB-ID: 2PBD (Ferron et al., 2007).  
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Actin export complex has proven itself not to be an easy target for crystallization. We 
optimized our purification conditions in the light of our findings to obtain a complex that is 
mostly stable over gel filtration. Nonetheless, the final product of complex purification 
may contain a slight heterogeneity due to the dissociation of the complex. An alternative 
approach to gel filtration is the purification of the complex via two affinity tags. 
Orthogonal proteases have been established in our lab for sequential affinity purifications, 
which can be used for purification of stoichiometric complexes (Frey and Gorlich, 2014). 
Our experiments show that the N-terminus of profilin and N-terminus of Ran are 
accessible in the context of the assembled complex and can be tagged for a sequential pull-
down from each sub-complex. 
Despite the possible inhomogeneity of the crystallization sample, we managed to identify a 
crystallization condition, where all four components of the actin nuclear export complex 
crystallized. This is a very crucial step forward, proving the potential of the complex to 
crystallize and showing that crystallization can be the best purification step itself. From 
this point on, we can only further improve the current condition and the crystals.  Besides 
the usual optimization workflow of crystallization, we can implement the improvements 
from Xpo6 crystallization to the complex, such as the optimally truncated Xpo6 constructs, 
or new Xpo6 species. Furthermore, we expect to find nanobodies against the export 
complex in our nanobody library. If we can identify a nanobody that stabilizes the interface 
of the two sub-complexes, this will greatly improve the purification and crystallization of 
the export complex. With the nanobodies, it is even possible that we find many other 
crystallization conditions for the complex. 
4.8 Exportin 6 and the IRM actin mutants  
We tried to establish an experimental strategy, in order to test our initial hypothesis that 
Xpo6 fails to recognize the mutant actins seen in IRM cases. The mutant actins have to be 
produced recombinantly. The most straightforward method is the in vitro translation (IVT) 
of the wild type and mutant actins with radiolabeled methionine. We designed an 
experimental set up as follows. Wild type actin and several IRM mutants are translated 
with rabbit reticulocyte lysate, and the translation reaction is used as a source for actin in 
our standard complex formation experiments (3.5.1). The actin (wt and mutants) in the 
input, flow through and in the Xpo6-bound fractions are detected by autoradiography. 
However, we failed so far to show a RanGTP dependent binding even for the positive 
control, the wild type α actin. The major problem was the low affinity of α actin towards 
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Xpo6. Also the cytoplasmic actin in the rabbit reticulocyte lysate acted as a competitor for 
Xpo6 binding. We could show Ran-dependent binding of actin to Xpo6, but this was only 
cytoplasmic actin from the lysate, as judged by the autoradiography.  
We will have to use another approach for testing the export capabilities of the IRM 
mutants. The best alternative is to use the Xenopus oocyte system for an in vivo export 
assay, which has been successfully used to show that Xpo6 can export different isoforms 
of actin and yeast actin (Bohnsack et al., 2006). In this experimental setup, radiolabeled 
actin mutants are produced with IVT, and the translation reaction is microinjected into the 
nucleus of Xenopus oocytes. Since the oocytes lack Xpo6, actin can only be exported if 
injected together with Xpo6. The localization of the radiolabeled products is determined by 
the dissection of the oocytes and the isolation of the individual nuclei. If our hypothesis 
holds true, we should see that the wild type α actin is exported, whereas the mutants fail to 
do so. However, Xpo6 will not only export the injected actin, but also the complete 
intranuclear actin meshwork of the oocytes. This represents the major challenge in this 
experimental setup. When the nuclear actin is exported, the nuclei become very fragile 
making the isolation a very tedious task, which is why we wanted to establish an 
alternative system in the first place. Despite the handling skills and the time it requires, this 
approach is very likely to give us definite answers about the export behaviors of the IRM 
actin mutants. 
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5 Outlook 
In this project we were able to biochemically characterize the actin nuclear export complex 
in detail. We describe the formation of a stable in vitro complex, by analyzing its 
limitations and drawbacks. Moreover, we describe the conditions for successful 
crystallization not only for the actin nuclear export complex, but also for human Xpo6 in 
its free form. With these findings, we set the foundation for structural understanding of 
cargo recognition by Xpo6. The identified crystallization conditions as well as the 
crystallization substrates will be improved as described in the result and discussion 
sections. Obtaining structural information of Xpo6 in its free form, of the Xpo6RanGTP 
complex and the complete export complex will provide us with a complete picture of the 
actin nuclear export. Analyzing the nuclear export of IRM actins by Xpo6 will help us to 
understand the mechanisms underlying intranuclear rod myopathies. 
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6 Materials and Methods 
6.1 Materials 
6.1.1 Chemicals 
All laboratory reagents were purchased from Calbiochem (San Diego, CA, USA), 
GibcoBRL-Life Technologies (Paisley, UK) Merck (Darmstadt, Germany), MoBiTech 
(Göttingen, Germany) Pharmacia (Uppsala, Sweden), Promega (Madison, WI, USA), 
Qiagene (Hilden, Germany), Roche (Mannheim, Germany), Roth (Karlsruhe, Germany), 
Sigma-Aldrich (St. Louis, MO, USA). 
6.1.2 Instruments 
Table 6-1 Laboratory equipments used in this study 
Instrument Manufacturer 
GenePulserTM BIORAD, Burlington, USA 
Eppendorf biophotometer Eppendorf, Germany 
Sonifier 450 Branson, UK 
UV-table Benda Laborgeräte, Wiesloch 
Perfection V700 Photo Scanner Epson 
Incubator/Climo-shaker ISF1-X Kuhner Shaker 
Thermomixer comfort Eppendorf, Germany 
Thermo NanoDrop 2000C peqLab, Germany 
SensoQuest lab-cycler SensoQuest, Göttingen 
Äkta-Explorer, Äkta-Purifier Pharmacia, Uppsala, Sweden 
DynaPro NanoStarTM Wyatt Technology, Dernbach, Germany 
MiniDAWNTM Treos® Wyatt Technology, Dernbach, Germany 
1260 Infinity Quaternary LC system Agilent Technologies, Waldbronn, Germany 
Cartesian 8-channel nanodispenser  Genomic solutions, Digilab Inc, MA, USA 
Freedom Evo liquid handling robot Tecan Group Ltd., Männedorf, Switzerland 
Rock Imager automatic imaging system Formulatrix Inc, Walthom, MA, USA 
Leica MZ6 microscope Leica microsystems 
 
Table 6-2 Centrifuges and rotors 
Centrifuge Rotor/Type Manufacturer 
Tabletop centrifuge 5424 Eppendorf, Germany 
Refrigerated tabletop centrifuge 5417R Eppendorf, Germany 
RC6 Plus centrifuge F9, F10, F21S FiberLite, F42 Sorvall 
WX Ultra centrifuge T647.5, T125.0 Sorvall 
Discovery M120 S45A, AT3 Sorvall 
 
6.1.3 Bacterial strains 
Different strains of E. coli were used for cloning and protein expression purposes. NEB10-
beta (C3019, New England Biolabs) strain was used for cloning, whereas NEBexpress Iq 
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(C3037, New England Biolabs), TOP10F’ (Invitrogen, Karlsruhe) and MDSTM42 (Scarab 
Genomics, LLC) strains were used for recombinant protein expression. TOP10F’ was used 
for expression of Ran constructs, MDS1 for expression of Xpo6 constructs for optimized 
yield. 
6.1.4 Media for E. coli cultures 
Table 6-3 E. coli culture media 
LB medium 2YT medium TB medium 
Used for DNA preparation 
cultures 
Used for transformant recovery 
protein expression pre/cultures 
Used for protein expression 
cultures 
10 g Tryptone 
5 g Yeast extract 
10 g NaCl 
ddH2O to 1 L 
16 g Tryptone 
10g Yeast extract 
5 g NaCl 
ddH2O to 1 L 
12 g Tryptone, 24 g Yeast extract 
10 mL (85%) Glycerol 
2.31 g K2HPO4, 16.4 g KH2PO4 
ddH2O to 1 L 
Autoclaved Autoclaved, 2% glycerol and 50mM 
K2HPO4 is added for protein 
expression cultures. 
0.5% Glucose is added for 
transformant recovery cultures. 
15g agar/L is added for agar plates. 
Autoclaved 
Antibiotic working concentrations:  Ampicillin:  100 µg/mL    
     Kanamycin: 50 µg/mL 
6.1.5 Buffers and solutions 
Buffers and solutions for DNA work 
50x TAE buffer 10x T4 DNA Ligase Buffer 10x PfuS buffer 
242 g Tris Base 
57.1 mL acetic acid 
100 mL 0.5 M EDTA pH 8.0 
ddH2O to 1 L 
500 mM Tris pH 7.5 
100 mM MgCl2 
100 mM DTT 
10 mM ATP 
250 µg/mL BSA 
 
200 mM Tris-HCl 
200 mM KCl 
15 mM MgSO4 
100 mM (NH4)2SO4 
1% Tween-20 
1 mg/mL BSA 
DNA ladder Orange G sample buffer  
50 ng/µL 1kb-Ladder  
in orange sample buffer 
10 mM Tris-HCl pH 8.0 
10 mM EDTA pH 8.0 
50% (w/v) glycerol 
25% (w/v) Orange G 
 
   
Buffers and solutions for protein work 
10x SDS running buffer SDS sample buffer Coomassie stock solution 
150 g Glycine 
30 g Tris Base 
12 g SDS 
ddH2O to 1 L 
125 mM Tris pH 6.8 
3% SDS 
50 mM DTT 
1 M Sucrose 
bromophenol blue 
2% Coomassie Brilliant Blue 
G250 in 50% ethanol 
Protein marker 
PageRuler Unstained protein 
ladder, Fermentas 
   
Resuspension buffer 1 (RS1) Resuspension buffer 2 (RS2) G-actin buffer 
500 mM NaCl 
50 mM Tris pH 7.5 
5 mM DTT 
500 mM NaCl 
50 mM HEPES/KOH pH 8.2 
2 mM MgCl2 
5 mM DTT 
2 mM Tris pH 8.0 
0.2 mM CaCl2 
0.2 mM ATP 
0.1 mM DTT 
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6.1.6 Commercial screens for crystallization 
AmSO4, Classics, Classics II, Classics Lite, JSCG+, MPD, MBClass, MBClass II, 
ProComplex, PEGs, PEGs II, PACT, ComPAS screens were obtained from Qiagen 
(Hilden, Germany); MIDAS screen was obtained from Molecular Dimensions (Suffolk, 
UK); SaltRx and Index screens were obtained from Hampton Research (Aliso Viejo, CA, 
USA) and Wizard 1+2, Wizard 3+4 screens were obtained from Emerald Biosystems 
(Bainbridge island, WA, USA) 
6.1.7 Software 
Lasergene Suite 9.0 programs (DNASTAR, Inc. Madison, WI), Oligo 6.8 (Molecular 
Biology Insights, Cascade, CO, USA) and online tools IDT oligoanalyzer 3.1 
(https://www.idtdna.com/analyzer/Applications/OligoAnalyzer/) were used for in silico cloning 
design and protein analysis. Gene designer 2.0.165 software (DNA2.0, Menlo Park, CA, 
USA) was used for design of gene synthesis constructs. Adobe Creative Suit 5 (Illustrator, 
Photoshop) were used for image preparation. Microsoft Office 2011 (for Mac) and 
Bookends 12.2 were used for writing and reference management. All crystal structure data 
was obtained from Protein Data Bank (PDB), visualization and analysis of the existing 
data and image preparation was performed with PyMOL (The PyMOL Molecular Graphics 
System, Version 1.5.0.4 Schrödinger, LLC.). For secondary structure predictions and 
sequence analyses, following online tools have been used: HHPred, PSI-BLAST and 
PSIPRED from bioinformatics toolkit of MPI for developmental biology 
(toolkit.tuebingen.mpg.de/), COBALT multiple alignment tool from NCBI 
(www.ncbi.nlm.nih.gov/tools/cobalt/) and Consensus secondary structure prediction tool  
(http://www.bioinf.manchester.ac.uk/dbbrowser/bioactivity/NPS2.html). Rock Maker software 
(Formulatrix, MA, USA) was used for the management of crystallographic work: design 
and pipetting of the crystallization screens, optimization of crystallization conditions, 
imaging and scoring of the crystallization drops. 
6.2 Methods 
6.2.1 Standard methods in molecular biology 
All standard methods described here were performed as described by (Sambrook, 2001)  
   85 
6.2.1.1 DNA purification from E. coli 
Plasmid DNA preparations from E. coli were done using NucleoSpin Plasmid kit 
(Macherey Nagel, Düren) at analytical scale (mini-prep), and using NucleoBond PC 100 
(Macherey Nagel, Düren) at preparative scale (midi-prep) according to the manufacturer’s 
instructions. 
6.2.1.2 Agarose gel electrophoresis 
DNA fragments were separated on agarose gels in 1x TAE running buffer. Agarose 
concentration of the gels varied between 1 – 1.5% in 1xTAE depending on the size of the 
fragments to be separated. 0.05 µg/mL ethidium bromide was added to liquid agarose for 
visualization. Samples were mixed with at least 1/5 volume of Orange G loading buffer. 
6.2.1.3 DNA isolation from agarose gels 
DNA fragments from agarose gels were extracted using the Zymoclean Gel DNA recovery 
Kit (Zymo research, Freiburg) according to the manufacturer’s instructions. DNA 
concentration was determined using Thermo NanoDrop 2000C spectrophotometer. 
(According to extinction at 260 nm (E260) and E260=1 corresponding to 50 µg/mL dsDNA) 
6.2.1.4 DNA restriction digestion & ligation 
All restriction enzymes (RE) were purchased from New England Biolabs and the 
digestions were performed according to the manufacturer’s instructions at 37ºC for 1-2 
hours. Vector preparations were dephosphorylated following the restriction digestion using 
Fast Alkaline Phosphatase (Fermentas) for 30 mins at 37ºC, in order to prevent reannealing 
of the vector and in order to reduce background during cloning. Vector (50ng) and insert 
fragments (3 fold molar excess to vector) were ligated using 100 ng/µl T4 DNA ligase 
(produced by Steffen Frey, department of cellular logistics) and 1x Ligase buffer in a 10 
uL reaction. For sticky-sticky ligations the reaction was incubated 30 mins at 37ºC, for 
blunt ligations overnight at 16ºC. A control reaction without insert DNA was run in 
parallel as a negative control. 1 µL of the ligation reaction was transformed into 
electrocompetent E.coli. 
6.2.1.5 Electroporation of E. coli  
Electrocompetent E. coli cells were prepared by Gabriele Kopp according to (Sambrook, 
2001) and aliquoted in ready-to use amounts, which are then stored at -80ºC. An aliquot of 
cells were slowly thawed and kept on ice. 45 uL of electrocompetent E.coli cells were 
combined with 1 uL of the ligation reaction (or with <20 ng plasmid DNA) in an 
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electroporation cuvette (BioRad), which is placed on ice. Electroporation was performed 
using GenePulser (BioRad) according to the manufacturer’s instructions. Cells were 
recovered in 1 mL 2YT+Glucose medium for 1h at 37ºC on a thermo shaker. The 
transformants are selected on 2YT-agar plates supplemented with corresponding 
antibiotics, overnight at 37ºC. 
6.2.1.6 Polymerase Chain Reaction (PCR) 
PCR was performed for the amplification of desired DNA fragments from DNA templates. 
Restriction sites for the subsequent cloning of the amplified DNA fragments were 
introduced to the 5’ overhangs of the primers, if not already present in the template vector. 
PfuS triple mix (a mixture of DNA polymerase, pyrophosphatase and dUTPase, prepared 
by Steffen Frey, department of cellular logistics) was used as the thermostable DNA 
polymerase, instead of the common Taq polymerase. PfuS is a fusion of Pfu polymerase 
with the thermostable DNA-binding domain of Sac7d or Sso7d, which provided high speed 
(~3.3 kb/min) and high fidelity proofreading to the DNA polymerase. A typical PCR 
reaction ingredients and standard PCR conditions used in this study are shown below. For 
the annealing step, the temperature was adjusted to a lower temperature than the melting 
temperature of the primers. In most cases, 62ºC was used as the standard. In problematic 
cases gradient PCR was performed. The annealing temperature was varied within the same 
block, to find the optimum conditions for the reaction. 
Table 6-4 PCR reaction ingredients 
Ingredient Amount 
DNA 50 ng 
Forward primer (100 µM) 1 µL 
Reverse primer (100 µM) 1 µL 
10x PfuS buffer 10 µL 
dNTP mix (2.5 mM each) 10 µL 
DMSO 2 µL 
PfuS triple mix 1µL 
ddH2O up to 100 µL 
 
Table 6-5 PCR conditions 
Step Duration Temperature Repeat 
Initial denaturation 2 min 98.5ºC - 
Denaturation 30 sec 98.5ºC  
30-35 cycles Annealing 30 sec Depends on primer Tm 
Elongation 1 min/2kb product 68ºC 
Final elongation 10 min 68ºC  
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6.2.1.7 Mutagenesis PCR 
Insertions, deletions or point mutations were introduced to a target vector by using 
mutagenesis PCR. Primers carried the nucleotides to be added to or mutated in the target 
vector at the 5’ ends, for deletions primers were designed to anneal next to the region to be 
deleted. The mixture for mutagenesis PCR is essentially the same as the normal PCR. The 
PCR reaction was either purified directly with Zymogen kit, or isopropanol precipitation is 
performed. 2 volumes isopropanol was added to the PCR reaction at RT and precipitated in 
a tabletop centrifuge at 14k rpm for 15’. The pellet was washed in 70% EtOH, shortly 
pelleted again and air dried carefully until all EtOH is evaporated. Pellet was resuspended 
in 88 µL of water, and combined with 10 µL NEB buffer 4 and 1 µL of DpnI (20 U/µL, 
NEB). The digestion reaction was incubated for >2h at 37°C. DpnI specifically cleaves 
methylated and hemimethylated DNA strands, degrading the template DNA and leaving 
the PCR produced strands intact. DNA was separated on 1% agarose gel and purified. 50 
ng of the DNA was phosphorylated (if primers were not already 5’ phosphorylated) and 
ligated as follows. 1 µL 10x T4 ligase buffer and 0.5 µL PNK (Fermentas) were added to 
the PCR product, the volume was brought to 9.5 µL with ddH2O. The reaction was 
incubated for 30 min at 37°C. 0.5 µL T4 DNA Ligase was added and incubated for another 
60 minutes. 1 µL of this mixture was transformed to 45 µL electrocompetent E. coli as 
described above. 
6.2.1.8 Gibson assembly reaction 
Gibson assembly reaction (GAR) (Gibson et al., 2009) was used for seamless cloning. It is 
especially useful in cases, where a suitable RE site can not be found, or when no additional 
amino acids are wanted within the construct resulting from a RE site between the tag and 
the desired protein. The insert template is created by PCR, with primers carrying the 
insertion sites to the vector at the 5’ end flanks. The vector can be just linearized between 
the insertion sites, or ideally also created by PCR. The insert created now carries 
overlapping (identical) sequences to the vector ends. Gibson assembly utilizes three 
enzymatic activities for the insertion of the template to the vector, a 5’-3’ T5 exonuclease, 
Phusion DNA polymerase and Taq DNA ligase, in a one step reaction (Gibson et al., 
2009). Exonuclease creates 3’ overhangs, which are compatible (by design) and can 
anneal. The Tm of the overlapping sequence is adjusted carefully for optimal annealing at 
the incubation temperature, that is 46ºC. After annealing, the gaps are filled by the 
polymerase, and nicks are annealed by the ligase. Equimolar amounts of vector and insert 
   88 
templates (15 fmol each, total 2 µL) is incubated with 2 µL of the home-made Gibson 
assembly mix (prepared by Dirk Görlich, Department of Cellular Logistics) at 46ºC for 30 
mins. Then 0.1-0.5 µL of this reaction is transformed to electrocompetent E. coli. 
6.2.1.9 Design and synthesis of oligos, DNA sequencing 
Primers were designed using Seqbuilder (Lasergene Suit) and Oligo 6.8 programs and 
online tools such as IDT oligoanalyzer 3.1. All oligos were ordered from Sigma-Aldrich 
DNA sequencing was performed by SeqLab (Göttingen) and results were analyzed by 
Seqman software (Lasergene Suite). The constructs for gene synthesis were designed using 
Gene designer 2.0.165 software for removal of possible RE sites and repetitive sequences 
from the constructs. All gene synthesis constructs were ordered from GenScript USA Inc. 
(NJ, USA). 
6.2.1.10 Bacterial expression vectors 
The table below lists the bacterial expression vectors created in this study and used in the 
experiments that are included in the thesis. The tag of the recombinant protein was either 
removed during purification, or left depending on the purpose of the further assays. 
Table 6-6 Recombinant expression vectors used in this study 
Plasmid name Expressed protein (with tags) Purpose  
pKG031 H14-zz-brSumo-hsRanQ69L(5-180) Human RanGTP used in all experiments 
pKG050 H14-zz-SumoStar-hsProfilin1 Tagged human profilin for profilactin / 
export complex formation in HeLa lysate 
pKG059 H14-zz-brSumo-hsProfilin1 Untagged human profilin used in complex 
formations / binding assays 
pKG061 H14-zz-SumoStar-hsXpo6 Tagged human Xpo6 for binding assays 
pKG063 H14-brSumo-xlXpo6 Xenopus Xpo6 for binding assays & 
alpaca immunizations 
pKG070 H14-brSumo-hsXpo6 Untagged human Xpo6 for complex 
formation and crystallization 
pKG091 H14-brSumo-hsXpo6-Tr1 Loop truncations for human Xpo6 
pKG092 H14-brSumo-hsXpo6-Tr2 Loop truncations for human Xpo6 
pKG093 H14-brSumo-hsXpo6-Tr3 Loop truncations for human Xpo6 
pKG094 H14-brSumo-hsXpo6-Tr4 Loop truncations for human Xpo6 
pKG095 H14-brSumo-hsXpo6-Tr5 Loop truncations for human Xpo6 
pKG096 H14-brSumo-hsXpo6-AL1 Loop truncations for human Xpo6 
pKG097 H14-brSumo-hsXpo6-AL3 Loop truncations for human Xpo6 
pKG099 H14-brSumo-hsXpo6-Tr6 Loop truncations for human Xpo6 
pKG108 H14-brSumo-ggXpo6 Chicken Xpo6 for binding assays 
pKG109 H14-brSumo-dpXpo6 D. purpureum Xpo6 for binding assays 
pKG111 H14-brSumo-dfXpo6 D. fasciculatum Xpo6 for binding assays 
6.2.1.11 SDS PAGE 
The analysis of the recombinant protein expression and purification as well as the binding 
assays, complex formation and gel filtration was performed with Sodiumdodecylsulfate 
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polyacrylamide gel electrophoresis (SDS-PAGE) followed by visualization of the proteins 
by Coomassie staining. The gradient SDS polyacrylamide gels were prepared by Gabriele 
Kopp according to the Table 6-7. Gels were run for 1h at 50 mA constant current in 1x 
SDS running buffer. Subsequently, proteins were fixed to the gel by heating the gel in 3% 
acetic acid and stained with a 1:100 dilution of the Coomassie stock solution. Gels were 
destained in H2O and documented using an EPSON scanner. 
Table 6-7 Gradient polyacrylamide gel solutions 
Ingredient Heavy gel (16%) Light gel (7.5%) Stacking gel (4.5%) 
app. for 10 gels 200 mL 200 mL 100 mL 
2 M Tris pH 8.8 40 mL 40 mL ---- 
0.5 M Tris pH 6.8 ---- ---- 15 mL 
H2O 32 mL 107 mL 68 mL 
2 M Sucrose 10 mL ---- ---- 
87% Glycerol 8 mL ---- ---- 
10% SDS 2 mL 2 mL 2 mL 
Rotiphorese Gel 30 108 mL 51 mL 15 mL 
TEMED 120 µL 120 µL 100 µL 
APS (10%) 2x580 µL 2x580 µL 1 mL 
 
6.2.2 Recombinant protein expression and purification 
6.2.2.1 Recombinant protein expression in E. coli 
All proteins except actin were expressed in E. coli strains, selected for the optimal yield 
(6.1.3). The optimal expression conditions were determined for each protein individually 
in order to maximize the yield. All proteins were purified natively. The common protocol 
for all recombinant expressions is described below. Variations are indicated for each 
construct. A pre-culture was inoculated in 2YT medium supplemented with appropriate 
antibiotics from a single colony, containing the desired construct. Pre-culture was grown 
overnight at 30-37°C with agitation. The next day, pre-cultures were used to inoculate the 
expression cultures in TB medium. The cultures were grown further at 30-37ºC and then 
diluted with more TB medium to OD600≈2, and brought to the expression temperature. 
The dilution step with pre-cooled medium enables a quick cooling of the cultures for cold 
expressions. For Ran and Xpo6 constructs expression was performed overnight at 18ºC, for 
profilin constructs 3-6 h at 25-30ºC. The cultures were grown at least 30 min at the 
expression temperature and expression was induced with varying concentrations of 
Isopropyl-β-D-thiogalactopyranosid (IPTG) (100 µM for Xpo6 and Ran, 200 µM for 
profilin). Expression was carried out under constant agitation (85-100 rpm). After the 
expression the density of the culture is measured. Prior to harvesting 1mM 
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phenylmethanesulfonylfluoride (PMSF) was added to the culture as protease inhibitor and 
the culture is poured to centrifuge tubes containing EDTA to a final concentration of 
10mM. Cells were sedimented for 10 mins at 6000 rpm using F9 rotor, Sorvall. Medium 
was removed and the cells were resuspended to 75-100 OD/mL concentration in their 
corresponding resuspension buffers (RS1 for Xpo6 and profilin constructs, RS2 for Ran 
constructs). The cells were flash frozen in liquid nitrogen. The resuspension can be stored 
at this stage for extended periods at -80ºC, or immediately processed further. 
6.2.2.2 Native protein purification with Ni2+ affinity chromatography 
The cell resuspensions were thawed in warm water and placed on ice. The freeze thaw 
cycle also contributes to the lysis of the cells. The resuspension was sonified 3x5min at 
40% duty cycle with output value of 10 (Branson Sonifier 450, CT, USA). Lysed cell 
suspension was ultracentrifuged at 37000rpm at 4°C for 1.5h in T 647.5 rotor. The 
supernatant, containing the soluble proteins, was used for affinity purification of the 
desired recombinant protein. Since all proteins expressed and used in this study have an N-
terminal 14-His-Tag, Ni2+ affinity chromatography was performed to enrich the 
recombinant proteins. The Ni-EDTA matrix (prepared by Dirk Görlich) was equilibrated 
with the corresponding resuspension buffer. The lysate (supernatant after 
ultracentrifugation step) was added to the equilibrated matrix and 15-20 mM imidazole 
was added to repress non-specific binding of bacterial proteins to the matrix. At this 
imidazole concentration, 14His tag can still efficiently bind to the matrix, whereas the 
contamination with bacterial proteins is significantly reduced. The binding to the matrix is 
done at least for 2h in cold room with gentle rotation. Matrix to lysate ratio was optimized 
for individual proteins for maximum recovery. The mixture was applied to a 
chromatography column of appropriate size. The flow-through was collected. The now 
protein-bound resin was washed twice with resuspension buffer containing 25-30 mM 
imidazole to remove low affinity contaminants. Elution of the protein was performed with 
resuspension buffer containing 0.5 M imidazole. The collected fractions were analyzed by 
Amido Black quick staining and peak fractions were pooled together. The protein 
concentration was determined using NanoDrop. Eluted protein in this case still contained 
the N-terminal tag. A buffer exchange was performed to remove the imidazole and bring 
proteins to desired conditions using PD10 desalting columns (GE healthcare). 
When the N-terminal tag was not needed any further, proteins were eluted by cleaving at 
the protease recognition site between the N-terminal affinity tag and the protein. In this 
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case after washing step, the corresponding protease (100nM for Sumo protease, >600nM 
for SumoStar protease, both prepared by Steffen Frey) in resuspension buffer containing 
5mM imidazole was quickly passed through the resin (by applying pressure) and cleavage 
was done >1h in cold room. The cleaved protein was collected by addition of more 
resuspension buffer containing 5mM imidazole. The collected fractions were analyzed by 
Amido Black quick staining and peak fractions were pooled together. The protein 
concentration was determined by measuring absorption at 280nm using NanoDrop, using 
the extinction coefficients calculated by Protean (Lasergene suit). The purity of the 
proteins was quite satisfactory with the described procedure. However, if additional 
purification was needed (for crystallization, or removal of protease or truncation products) 
protein was subjected to size exclusion chromatography (gel filtration). Purified proteins 
were aliquoted, supplemented with 250 mM sucrose as cryoprotectant, flash-frozen in 
liquid nitrogen and stored at -80ºC. Gel samples were taken at each step of 
expression/purification in order to follow the induction, solubility, stability and purity of 
the protein.  
6.2.2.2.1 Purification of Ran constructs 
Purification of Ran was a little more elaborate than the others, due to the bound nucleotide. 
In this study, a mutant (Q69L) and truncated version of Ran (5-180) was used. Q69L 
mutation prevents the GTPase activity of Ran (Klebe et al., 1995), hence the mutant Ran 
can not hydrolyze GTP. The C-terminal switch destabilizes the GTP-bound of Ran and 
weakens NTR interactions (Richards et al., 1995). In order to keep Ran in GTP bound 
form, special steps were implemented in its purification. After binding to Ni-matrix 30 µM 
GTP was added in all steps, and an additional wash step with 2 mM ATP was included, to 
remove bound bacterial chaperones. After the elution from Ni-matrix, protein was applied 
to SP-sepharose cation exchange chromatography and eluted with increasing salt. This way 
I could remove a major truncation that occurred during recombinant expression or the 
sumo protease used during cleavage. But also GTP-bound actin can well be separated on 
SP-sepharose than other nucleotide forms, such that one obtains a homogenous Ran sample 
in GTP bound form. 
The nucleotide states of Ran constructs were controlled by the following protocol. 500 µL 
of 15 µM Ran was buffer exchanged to 50 mM Tris pH 7.5, denatured at 95ºC for 5 mins. 
The solution was immediately diluted to 2 mL with 50 mM Tris pH 7.5. Precipitants were 
removed by centrifugation at 14k rpm in a cooled tabletop centrifuge. The supernatant was 
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applied to a MonoQ HR 5/5 column equilibrated with 50 mM Tris pH 7.5, and the salt 
concentration was increased in a shallow gradient to 500mM. The bound nucleotide 
(GTP/GDP) can be well separated with this protocol, and the results are compared to a 
GDP/GTP standard to determine the nucleotide state. 
6.2.3 Purification of skeletal muscle actin 
Actin was purified from chicken muscle acetone powder as described in (Spudich and 
Watt, 1971; Pardee and Spudich, 1982) with some minor modifications to the procedure. 
All steps were carried out in the cold room. All materials and buffers involved in the 
purification were placed into the cold room the night before use. 1000g of very fresh, 
skinless, boneless chicken breast was purchased on the day of delivery, and brought to the 
lab in a cool box. All fat or remaining blood vessels were removed from the meat. The 
meat was cut into smaller pieces and finely ground using a meat grinder. All connecting 
tissues, that were building up during the grinding procedure were removed. The mince was 
extracted in five steps using sterile cheesecloth to separate extract and cell mass. 
Extraction 1: The mince was stirred for 10 minutes in 1 L ice-cold extraction buffer I (0.1 
M KCl, 0.15 M Potassium phosphate; pH 6.5). The extract was filtered using sterile 
cheesecloth. 
Extraction 2: The mince was further stirred in 2 L ice-cold extraction buffer II (0.05 M 
NaHCO3) for 5 minutes. It is important not to exceed the extraction time in this buffer as it 
reduces the actin yield. The extract was filtered using sterile cheesecloth. 
Extraction 3: The mince was stirred 10 minutes in 1 L ice cold extraction buffer III (1 mM 
EDTA, pH 7.0) and filtered using sterile cheesecloth. 
Extraction 4: The mince was extracted twice in 1 L ice-cold water for 5 minutes by 
constant stirring and filtered using sterile cheesecloth. 
Extraction 5 (repeated five times): The final five extractions were each in 1 L ice cold 
acetone for 10 minutes by carefully stirring with a glass rod. The extractions were done at 
room temperature in a fume hood but the acetone was kept ice cold at all times. Each 
extraction was filtered using sterile cheesecloth. 
The final extract was spread in a large tray formed with aluminum foil. The tray was 
covered with clean cheesecloth, making sure that the cloth did not touch the mince. The 
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mince was air dried in a hood over night. The dried acetone powder was filled into 50 ml 
Falcon tubes and stored at - 80°C. The acetone powder is stable for several months/years. 
11 g Acetone Powder was resuspended with 220 mL G-actin Buffer and stirred slowly at 
room temperature for 30 minutes. The liquid was collected and the remaining debris was 
resuspended with 150 mL more G-actin buffer for 5 more minutes. The liquid collected 
(approximately 300 mL) was centrifuged at 18000 rpm 4°C for 30 min in F21 rotor 
(Sorvall). The supernatant volume was measured and for 300 mL of supernatant, following 
ingredients were added while slowly stirring at room temperature: 
5 mL of 3 M KCl   (50 mM final) 
0.6 mL of 1 M MgCl2  (2 mM final) 
3 mL of 0.1 M ATP  (1 mM final) 
Under these conditions, actin was left to polymerize for 1h at room temperature, with slow 
stirring. After 1h solution became thick and viscous indicating polymerization of G-actin 
into F-actin. KCl concentration was increased to 0.6 M by adding 12 g of KCl as powder 
while stirring. The solution was stirred for 20-30 more minutes at room temperature. The 
solution was centrifuged at 42000 rpm 4°C for 1h in T1250 rotor. The pellet containing the 
F-actin was resuspended with G-actin buffer up to 15 mL volume. The resuspension was 
dialyzed against G-actin buffer for 48 hours in a dialysis bag with a cutoff value 6-8000 
Da. The buffer was changed three times in 48 hours. The solution afterwards was 
centrifuged at 95000 rpm 4°C for 30min in S55A rotor in order to get rid of precipitates 
and impurities.  
G-actin concentration determination: [G-actin (mg/ml)] = (Abs290 /0.62) x dilution factor 
6.2.4 HeLa cytoplasmic extract preparation 
HeLa cytoplasmic extracts were a courtesy of Dr. Berthold Kastner, Department of cellular 
biochemistry, MPI-BPC. The protocol is based on (Mayeda and Krainer, 1999), with some 
modifications. 4 liters of HeLa resuspension culture was pelleted and the pellet was 
washed 3x with 1x PBS (10x PBS: 130 mM NaCl, 20 mM KPO4) 10 min each. Pellet is 
weighed and weight (in g) was multiplied by 0.96 to get the packed cell volume in ml. This 
value was then multiplied by 0.03 to get the cell number (in 1010). The cells were then 
resuspended in 1.25x volume MC buffer (10 mM HEPES KOH pH 7.6, 10 mM KOAc, 0.5 
mM MgOAc, 5 mM DTT, 1x complete EDTA free proteinase inhibitor). The resuspension 
was incubated 5 min on ice and homogenized with 18 strokes using cell homogenizer. The 
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homogenate was pelleted in Corex tubes at 13000 RCF in SS34 rotor for 5 min. The 
supernatant was the S10 cytoplasmic extracts used in this study. The S10 extract was 
aliquoted and frozen in liquid nitrogen. The extract is stable at -80ºC. The S10 extract was 
further cleared at 90000xg before use in the binding experiments. 
6.2.5 DNaseI coupling to cyanogen bromide activated sepharose 
In order to test the accessibility of actin’s D-loop in the export complex, DNaseI matrix 
was prepared by coupling DNaseI from bovine pancreas (Sigma, D-5025) to cyanogen 
bromide-activated-Sepharose® 4B (Sigma, C9142). 500 mg matrix was washed with 1 mM 
HCl and let to swell for 30 min at room temperature. After swelling, the matrix was 
washed with 100 mL of 1mM HCl, 10 mL water and with 2 mL coupling buffer (CB: 0.1M 
Na HCO3 50mM NaCl pH 8.3) immediately before the coupling reaction. In the meantime, 
5mg DNaseI was dissolved in 3mL CB (1.6 mg/mL) and was incubated with 100uL 
Aprotinin matrix (16 mg/mL) for 15 min to remove the trypsin from the sample. The 
matrix was removed by centrifugation at 500 rpm for 1 min on a tabletop centrifuge. 
Optionally, DNaseI can be incubated with protease inhibitors like PMSF for another 30-60 
min. The concentration of the protein was measured with absorbance at 280 nm. The NaCl 
concentration was increased to 500 mM. The washed matrix was split into two. One part 
was incubated with DNaseI and the other part with CB+500 mM NaCl over night in cold 
room. Next day, the flow through was taken and the protein concentration was measured. 
Absorbance zero at 280 nm, means that all DNaseI was coupled to the sepharose matrix. 
Both matrices were washed with CB and quenched with 1M Tris pH 8.0 in 1:1 CB for 2 h 
at room temperature. The matrices were extensively washed with CB and with 0.1M 
Acetate buffer pH 4.0, 0.5M NaCl. The wash was repeated 4-5 times. The matrix was 
stored in 1M NaCl at 4ºC. 
6.2.6 Binding assays for complex formation 
Binding assays were performed with purified components to test various conditions for 
their effect on complex formation. HeLa S10 extract was used as a source of cytoplasmic 
actin. Buffer conditions and additives varied depending on the purpose of the experiment, 
but the following conditions were kept constant. Binding assays were carried out in small 
mobicol columns plugged with 35 µm pore size filters (MoBiTech, Göttingen). For most 
of the assays shown in this work, profilin was used as the tagged component, where all the 
other members of the complex were assembled. 50 µL of undiluted cleared S10 extract and 
250 pmol profilin was incubated in the presence of 5mM EDTA for 1h in cold room. This 
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was then diluted to 500 µL with binding buffer with the addition of 20 µL affinity matrix. 
The complex was immobilized on Ni-matrix via the N-terminal 14-His of the tagged 
component for 1-2h in cold room with gentle rotation. The flow through (FT) was taken 
and the matrix was washed with 2x200 µL binding buffer. Then again in 500 µL binding 
buffer, Xpo6 (1 µM) and RanGTP (1.2 µM) were added to the matrix and incubated for 3h 
in cold room with gentle rotation. Xpo6 and Ran were pre-mixed for 1-2h without dilution, 
prior to addition to the matrix. FT was taken and the matrix was washed with 2x200 µL 
binding buffer. The complex was then eluted by cleavage of the tag with protease. 
SumoStar tagged components and respectively SumoStar protease were used in the binding 
assays, because the SumoStar substrate could not be cleaved by the eukaryotic proteases 
present in the S10 extract.  
Another set of binding assays were performed on phenyl sepharose (PS) matrix (Phenyl 
SepharoseTM 6 Fast Flow (low subst.), Amersham Bioscience), which binds to nuclear 
transport receptors. In this case, all components were untagged. S10 extract and profilin 
were pre-incubated for 1h, which was followed by the addition of Xpo6 and RanGTP and 
10 µL PS matrix. FT was taken and the matrix was washed with 2x200 µL binding buffer. 
Xpo6 and all the other proteins that were bound to Xpo6 were retrieved from the matrix by 
SDS elution. The control experiments were performed without Xpo6, to ensure that the 
binding of the other components to PS matrix is specifically via Xpo6.  
6.2.7 Actin export complex formation for crystallization 
The export complex was formed in a two-step procedure in large scale for crystallization. 
50 mL of undiluted, ultracentrifugation cleared S10 HeLa cytoplasmic extract was 
combined with 600 µL of 500 µM tagged profilin in the presence of 5 mM EDTA in cold 
room with gentle rotation for 1h. This was diluted to 250 mL with binding buffer (10 mM 
Tris pH 7.5, 20 mM NaAc (sodium acetate, CH3COONa, pH adjusted to 7.5), 1 mM DTT) 
and 6 mL Ni-matrix (equilibrated with binding buffer) was added in the presence of 10 
mM imidazole, to reduced unspecific binding from S10 extract to Ni-matrix. This was 
incubated in cold room for 2-2.5h with gentle rotation. FT was taken and the matrix was 
washed with 10 mL binding buffer with 10 mM imidazole and 10 mL of complex buffer 
(10 mM Tris pH 7.5, 20 mM NaAc, 2 mM MgAc2 (magnesium acetate, Mg(C2H3O2)2), 1 
mM DTT) with 5mM imidazole. 7 mL of 56 µM Xpo6 and 4.5 mL of 93 µM RanQ69L(5-
180) were mixed and incubated 2h in cold room without dilution. This mixture was buffer 
exchanged to complex buffer using PD10 desalting columns (GE healthcare). It was added 
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to the Ni-matrix in 30 mL total volume in 5mM imidazole. Binding was performed >3h, 
preferentially overnight. The longer incubation times increased the final yield of export 
complex. FT was taken, the matrix was washed with 10 mL complex buffer with 5 mM 
imidazole. The tag of profilin was cleaved with 200 nM SumoStar protease in 6mL 
complex buffer + 5mM imidazole. The complex was eluted with complex buffer + 5mM 
imidazole. Fractions were analyzed by amido black quick staining, pooled and 
concentrated. The sample was ultra centrifuged (90000x g) to remove aggregates and was 
applied to a SuperdexTM 200 16/60 gel filtration column (GE healthcare) equilibrated with 
complex buffer. The gel filtration fractions were analyzed, pooled and concentrated to 
~15mg/mL for crystallization purposes. Sample that was not immediately used for 
crystallization was aliquoted and snap-frozen in liquid nitrogen and stored at -80ºC. This 
procedure yielded approximately 30 mg of high purity actin export complex. 
For Xpo6RanGTP complex crystallization, purified and untagged proteins were mixed in 
a 1:1.2 ratio (Xpo6:RanGTP), incubated 2-3h at 4ºC, buffer exchanged into 10 mM Tris 
pH 7.5, 20 mM NaAc 20, 2 mM MgAc2, 1 mM DTT and applied to Superdex 200 16/60 
size exclusion column. The sample was concentrated to 15 mg/mL. 
For Xpo6 crystallization, affinity purified Xpo6 was concentrated, buffer exchanged to 10 
mM Tris 7.5, 50 mM NaCl, 1 mM DTT, applied to Superdex 200 16/60 size exclusion 
column. The sample was concentrated to 17 mg/mL. 
6.2.8 Thermal stability analysis with Thermofluor 
Thermofluor experiments were performed to test the thermal stability of Xpo6, 
Xpo6RanGTP and the actin export complex. Each sample was diluted to 5 µM in 20µL of 
complex buffer (10 mM Tris pH 7.5, 20 mM NaAc, 2 mM MgAc, 1mM DTT) containing 
1x Sypro-Orange (Life Technologies). Three replicates of each sample (20 µL) were 
pipetted in a Hard-Shell® 96-well plate (Bio-Rad). The plate was sealed with transparent 
MicroSeal® ‘B’ Seal (Bio-Rad) and briefly centrifuged to remove air bubbles from the 
wells. For the assay, CFX96 Real-Time System (C1000 Thermal Cycler, BioRad) was 
used. The temperature was gradually increased (with 1ºC increments per cycle) from 30ºC 
up to 95ºC. The Sypro-Orange fluorescence was measured after each temperature 
increment using the HEX channel. The raw data of the measurements were exported as 
excel sheets for further analysis. Graphical representations were prepared using Microsoft 
Excel 2011 for Mac. 
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6.2.9 Molecular weight analysis with static light scattering 
To determine the molecular weight of the complex, multi angle light scattering (MALS) 
was employed. The technique is based on two main principles: First, the amount of light 
that is scattered by a particle (protein, in this case) is directly proportional to the product of 
the molar mass and the molecular concentration. Second, the variation of scattered light 
with the scattering angle is proportional to the average size (radius) of scattering molecules 
(for particles with diameter > λ/20). In the system we employ (miniDAWN TREOS), a 
high intensity polarized light (659 nm) is shot onto sample and the scattered light is 
detected at three different angles. This information together with measurements of 
concentration (UV and refractive index measurements) is used for the calculation of the 
molecular weight of the sample. The physical equations are not described here. The device 
is coupled to a gel filtration system, such that the sample is size separated before being 
analyzed. Calculations and analysis of results were performed by Astra® 6 software (Wyatt 
Technology Europe). 
6.2.10 Polydispersity analysis by dynamic light scattering 
Dynamic light scattering is used to determine the size distribution profile of a given 
particle solution. Particles scatter light, and the intensity of the scattered light at a given 
angle fluctuates over time, because the particles undergo Brownian motion. The rate at 
which particles diffuse in a solution is related to their size (hydrodynamic radius Rh), when 
all other parameters are constant. DLS measures the fluctuations in light scattered by the 
sample over time in order to determine the size distribution of the particles in the sample. 
Thus, DLS can be used as a measure of sample heterogeneity (dispersity). A non-uniform 
(polydisperse) collection of particles is not ideal for crystallization; rather a homogenous 
(monodisperse) sample is desired. We used DynaPro NanoStar (Wyatt Technology 
Europe) for DLS measurements of the crystallization samples as a quality control. 10 µL 
of sample is used per measurement with 20 acquisitions of 5 second each. DLS can also be 
used to analyze the size distribution of a given sample over a temperature range. This 
method was applied as an alternative to thermofluor assays to determine the 
thermostability of crystallization substrates. 
6.2.11 Limited proteolysis of crystallization substrates 
In order to identify flexible regions in the crystallization substrates, limited proteolysis was 
applied. 3 µg protein was incubated with a dilution series of proteases (Trypsin – 
Chymotrypsin, Promega, Germany / GluC, Roche, Germany) for 1 h at 22ºC. The 
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concentration of the protease varied between 10 ng/µL and 8 pg/µL. 15 µL of SDS sample 
buffer containing 5 mM EDTA and 5mM PMSF was added and the reaction was incubated 
at 95ºC for 5 minutes to stop the reaction. 10 uL of this sample was analyzed with SDS-
PAGE and bands of interest were cut and analyzed by mass spectrometry. 
6.2.12 Mass spectrometry  
The MS-MS analysis of the fragments created by limited proteolysis was done by Mass 
spectrometry in Henning Urlaub Lab, MPI-BPC. A more detailed analysis of the identified 
peptides and the identification of the protease cut sites was kindly done by Samir Karaca, 
using Maxquant software. 
6.2.13 Protein crystallization 
Proteins and protein complexes were purified to highest possible degree with affinity and 
size exclusion chromatography techniques and brought to high concentrations for 
crystallization. We used an automated system for large scale screening of crystallization 
conditions at the crystallization facility of MPI-BPC, run by Dr. Vlad Pena. As a general 
approach, vapor-diffusion method was used for crystallization. In this method, a small 
volume of the concentrated protein sample is mixed with the same volume of 
crystallization solution (reservoir, mother liquor), which consists of buffer, salt or 
precipitant; generally a combination of all three. The drop is incubated with the reservoir in 
an air tight sealed chamber, but with no physical contact to the reservoir. Two types of 
vapor diffusion techniques are used: the drop is either placed on a coverslip which seals the 
chamber from the top (hanging drop), or on a well above the reservoir level in the 
chamber, which is again tightly sealed (sitting drop). The difference in the concentration of 
components (mainly precipitant) between the drop and reservoir solution causes vapor 
diffusion of the solvent until equilibrium is reached. Shrinking of the drop due to water 
loss, leads to super saturation of the protein, which favors crystallization, under optimal 
conditions. With the robotic system, sitting drop vapor diffusion method was utilized in 
96-well MRC plates (Molecular Dimensions, UK). In manual crystallization experiments, 
we employed hanging drop method. 
6.2.13.1 Sparse matrix screening 
There are a number of commercially available crystallization screens based on previous 
successful crystallization conditions and their derivations (sparse matrix screens). This is 
today the most commonly employed approach for initial crystallization trials. A broad 
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spectrum of conditions (randomly) screened for hits. Crystallization drops were set up in 
96 well sitting drop MRC plates (Molecular dimensions) using Cartesian Microsys Nano 
dispenser robot. 60nl of reservoir was pipetted followed by 60nl of protein (15-17 mg/ml) 
into the round wells of MRC plates. After pipetting, the plates were sealed tightly with a 
clear sealing tape and stored at 20°C or 4°C (both temperatures were screened for each 
condition) in automated robotic imager (Formulatrix). Crystal growth was monitored over 
time using Rock Maker software (Formulatrix), which was used to take images of the 
crystallization drops at regular intervals.  
6.2.13.2 Grid screening  
When an initial crystallization hit was obtained from sparse matrix screens, the 
corresponding condition was further optimized for increased crystal quality and size by 
screening around the initial crystallization conditions (grid screening). Grid screens were 
designed using RockMaker software (Formulatrix) by varying the concentration and pH of 
components in the initial hit condition around their original concentration and pH. The 
plates were pipetted as described for sparse matrix screens and monitored on regular 
intervals. 
6.2.13.3 Manual drops 
For crystallization experiments such as in-situ proteolysis, seeding, or just to obtain larger 
crystals manual drops were set in microliter scale. Hanging drop method was employed, 
using 24‐well EasyXtal tool (QIAGEN) plates with grease-free screw lids. 400 µL of 
reservoir was placed in the well; 1‐2 µL of reservoir was mixed with 1‐2 µL of protein 
solution on the cover slip/lid. The lid is tightly screwed, and the plate is incubated in cold 
room / at room temperature. The dropswere monitored at regular time intervals by visual 
examination under Leica MZ6 microscope (Leica Microsystems). 
6.2.13.4 Seeding 
Seeding is a crystallographic technique where imperfect crystals are used to grow better 
diffracting, bigger crystals. The logic is to overcome the rate limiting nucleation step of 
crystallization. It is especially important, when the identified first hits can not easily be 
reproduced. The conditions required for nucleation and crystal growth might not always be 
identical. We used microseeding, to reproduce or improve crystals. The initial crystals 
were taken to a loop and washed in a fresh reservoir solution, and eventually left in the 
reservoir condition, where they grew. In 20 µL reservoir in an eppendorf tube, the crystals 
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were crushed by vigorous vortexing and subsequent sonication in a waterbath. This seed 
stock is then further diluted and the dilution series are mixed 1:1 with new protein sample 
for crystallization.  
6.2.13.5 Cryoprotection, crystal fishing and data collection 
When a crystallization drop was to be harvested, the solution was slowly exchanged to a 
“cryo-condition” without disturbing the crystals. This prevented ice formation inside or 
surrounding the protein crystal during freezing The cryo-protectant solution had the 
identical buffer and salt conditions as the reservoir, the precipitant (in this work, mostly 
PEG) concentration was increased to 25%, and another suitable cryo‐protectant (glycerol, 
ethylene glycol, xylitol, sucrose, PEG 400) was added if precipitant increase wasn’t 
enough. After the drop solution was replaced with the cryo-colution, crystals were 
carefully fished with Nylon-loops mounted on a magnetic head (mounted CryoLoops, 
Hampton Research) of 0.06 - 0.5 µm in size. Fished crystal was immediately in liquid 
nitrogen for freezing. Diffraction data from cryo‐cooled crystals were collected at 100 K 
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7 Abbreviations 
aa   Amino acid 
ABP   Actin binding protein 
ADP   Adenosine 5’-diphosphate 
ATP   Adenosine 5’-triphosphate 
ATPase   ATP hydrolase 
CAS   cellular apoptosis susceptibility (a.k.a. Exportin 2) 
CRM1   Chromosomal region maintanence-1 (a.k.a. Exportin 1) 
C-terminus  Carboxy-terminus 
DMSO   Dimethyl sulfoxide 
DNA   Deoxyribonucleic acid 
DTT   Dithiothreitol 
E. coli   Escherichia coli 
EDTA   Ethylene diamine tetraacetic acid 
Exp/Xpo  Exportin 
F-actin   Filamentous actin 
FG   Phenylalanine/Glycine 
G-actin   Globular actin 
GDP   Guanosine 5’-diphosphate 
GFP   Green fluorescent protein 
GTP   Guanosine 5’-triphosphate 
h   hours 
HEPES   4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
His-tag   (in this study) amino terminal tag of 14 Histidine residues 
Imp   Importin 
IPTG   Isopropyl-β-D-thiogalactoside 
kDa   kilo Dalton 
LB   Luria Bertani medium 
MALS   Multi angle light scattering 
MDa   mega Dalton 
min   minutes 
N-terminus  Amino-terminus 
NE   Nuclear envelope 
NES   nuclear export signal 
NLS   nuclear localization signal 
nmol   nanomole 
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Nup   Nucleoporin 
NPC   nuclear pore complex 
PEG   polyethylene glycol 
PIP2   Phosphatidylinositol 4,5-bisphosphate 
PS   Phenyl sepharose 
RanGTP  (GTP-bound)Ras related nuclear antigen 
rpm   rotation per minute 
SDS-PAGE  Sodium dodecyl sulfate gel electrophoresis 
Sumo   Small ubiquitin like modifier 
Tris   Tris(hydroxymethyl)aminomethane 
Xpo6   Exportin 6 
w/v   weight per volume 
µm   micrometer 
µM   micromolar 
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